RESULT_COUNT: 341,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : October 18, 2017",2017-10-18 13:47:02 +0000,http://finance.yahoo.com/r/d3291357-c95f-3f2d-a450-f1e2a60abd5c/etfs-with-exposure-to-halozyme-therapeutics-inc-october-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Halozyme Therapeutics, Inc. Here are 5 ETFs with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-10-17 12:06:45 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120645504.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HALO,HALO:UW,BBG000CZB639,3 Drug Stocks Hitting 52-Week Highs: Are They Buys?,2017-10-17 11:32:00 +0000,https://finance.yahoo.com/news/3-drug-stocks-hitting-52-113200004.html?.tsrc=rss,2017 has been a great year for these drug stocks. But will their momentum taper off?
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-10-16 13:46:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-134647436.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HALO,HALO:UW,BBG000CZB639,Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients,2017-10-16 12:00:00 +0000,https://finance.yahoo.com/news/halozyme-initiates-clinical-trial-pegph20-120000829.html?.tsrc=rss,"PEGPH20, atezolizumab Combination to be Evaluated Under Clinical Collaboration SAN DIEGO , Oct. 16, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced initiation of a clinical ..."
HALO,HALO:UW,BBG000CZB639,Today’s Research Reports on Trending Tickers: Halozyme Therapeutics and Akers Biosciences,2017-10-13 12:00:00 +0000,https://finance.yahoo.com/news/today-research-reports-trending-tickers-120000918.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 13, 2017 / Major Indexes pulled back on Thursday as investors digested earnings from JPMorgan Chase and Citigroup. The Dow Jones Industrial Average declined 0.14 percent ..."
HALO,HALO:UW,BBG000CZB639,Halozyme to Host Third Quarter 2017 Financial Results Conference Call,2017-10-10 12:00:00 +0000,https://finance.yahoo.com/news/halozyme-host-third-quarter-2017-120000408.html?.tsrc=rss,"SAN DIEGO , Oct. 10, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,3 Monster Stocks in the Making,2017-10-10 10:03:00 +0000,http://finance.yahoo.com/r/732a2dad-3659-3bd7-a993-926f0d50dd7d/3-monster-stocks-in-the-making.aspx?yptr=yahoo&.tsrc=rss,"Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns."
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : October 6, 2017",2017-10-06 14:53:15 +0000,http://finance.yahoo.com/r/98e9ff29-bb15-300e-b164-b68851898d27/etfs-with-exposure-to-halozyme-therapeutics-inc-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Halozyme Therapeutics, Inc. Here are 5 ETFs with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017",2017-10-05 13:34:42 +0000,http://finance.yahoo.com/r/e7d3371b-c3e3-3de8-b916-d3b09c09b3f0/halozyme-therapeutics-inc-halo-us-earnings-analysis-q2-2017-by-the-numbers-october-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Halozyme Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Halozyme Therapeutics, Inc. – Peregrine Pharmaceuticals, Inc. (PPHM-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 33.75 million, Net Earnings of USD -30.76 ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-10-02 12:05:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120523367.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,1 Great Biotech Stock You Have Never Heard Of,2017-09-29 15:34:00 +0000,http://finance.yahoo.com/r/83f334cc-d023-39f1-b406-6a4792d540fa/1-great-biotech-stock-you-have-never-heard-of.aspx?yptr=yahoo&.tsrc=rss,Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
HALO,HALO:UW,BBG000CZB639,"Tax Rate Down, Market Up",2017-09-28 13:43:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t9rIwhnNiF0/tax-rate-down-market-up-cm852291,The market has been waiting a long time for this Nine months since the election President Trump and the Republicans finally released their tax reform plan The proposal will now be studied debated and probably changed in the coming weeks but a couple of the basic ideas are a reduction in
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-09-28 12:05:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120653709.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,Can Halozyme (HALO) Run Higher on Strong Earnings Estimate Revisions?,2017-09-22 14:40:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OQKuzHgxGKc/can-halozyme-halo-run-higher-on-strong-earnings-estimate-revisions-cm849539,Halozyme Therapeutics Inc HALO is a therapeutically driven development stage biopharmaceutical company which could be an interesting play for investors That is because not only does the stock have decent short term momentum but it is seeing solid activity on the earnings estimate
HALO,HALO:UW,BBG000CZB639,Can Halozyme (HALO) Run Higher on Strong Earnings Estimate Revisions?,2017-09-22 12:35:12 +0000,https://finance.yahoo.com/news/halozyme-halo-run-higher-strong-123512754.html?.tsrc=rss,Halozyme Therapeutics (HALO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
HALO,HALO:UW,BBG000CZB639,"Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook",2017-09-20 14:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WunUELYk5dA/biotech-stock-roundup-fda-nod-for-first-cancer-biosimilar-halo-up-on-deals-raised-outlook-cm848300,A key development this week was the FDA approval of the first cancer biosimilar Amgen AMGN and Allergan s Mvasi a biosimilar version of Roche s blockbuster cancer drug Avastin Other updates include important data presentations from companies like Nabriva Therapeutics NBRV and AbbVie
HALO,HALO:UW,BBG000CZB639,"Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook",2017-09-20 12:45:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-fda-nod-124512730.html?.tsrc=rss,"Data presentations, regulatory updates and licensing deals were among the key highlights this week with the focus being on the FDA approval of the first cancer biosimilar - Amgen&apos;s (AMGN) Mvasi."
HALO,HALO:UW,BBG000CZB639,"Keep An Eye On These Biotech Stocks This Month, If Invested",2017-09-18 03:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T8NAdeCJXKk/keep-an-eye-on-these-biotech-stocks-this-month-if-invested-20170918-00105,"Keep An Eye On These Biotech Stocks This Month, If Invested"
HALO,HALO:UW,BBG000CZB639,"Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?",2017-09-16 16:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u53HUED6s14/halozyme-inovalon-and-teva-soared-this-week-can-they-go-higher-cm846722,Many healthcare stocks muddled along over the past week That wasn t the case though for three stocks of companies operating in very different parts of the healthcare spectrum Shares of Halozyme Therapeutics NASDAQ HALO Inovalon Holdings NASDAQ INOV and
HALO,HALO:UW,BBG000CZB639,"Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?",2017-09-16 14:47:00 +0000,http://finance.yahoo.com/r/1d856052-bb96-3c0c-98c3-8d02fbb0dc0c/halozyme-inovalon-and-teva-soared-this-week-can-th.aspx?yptr=yahoo&.tsrc=rss,Prospects for two of this week&apos;s big healthcare winners look great. But it&apos;s a different story for one of them.
HALO,HALO:UW,BBG000CZB639,[$$] Charting the Market,2017-09-16 03:33:00 +0000,http://finance.yahoo.com/r/08cb4dfd-a1ee-30f3-94e0-a5a8796fe8c7/charting-the-market-1505532788?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries  Drug-industry veteran Kare Schultz will be the new CEO of the world’s biggest generic-drug firm, which is struggling with competition and debt.  Oasis Petroleum  A Morgan Stanley report argued oil companies like Houston-based Oasis won’t face pricing pressure, as the increased cost of fracking buoys oil prices.  Universal Insurance Holdings  As Hurricane Irma hurt Florida less than feared, investors returned to insurance stocks like Universal, as well as Chubb, Travelers, and Everest Re Group."
HALO,HALO:UW,BBG000CZB639,"Halozyme Up After Cancer Deal, Markets Down",2017-09-15 16:34:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y3qo6gjDYmU/halozyme-up-after-cancer-deal-markets-down-cm846403,U S stock market indexes opened lower on Thursday Futures for the Dow Jones Industrial Average declined 3 points to 22 109 The Standard amp Poor s 500 index futures lost 2 points to 2 493 and futures for the Nasdaq 100 index declined 7 points to 6 002 The dollar index is down 0 06 at 92
HALO,HALO:UW,BBG000CZB639,Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE,2017-09-15 15:42:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oaOk_jZRM3U/bristol-myers-bmy-collaborates-with-halozyme-for-enhanze-cm846293,Bristol Myers Squibb Company BMY recently entered into a collaboration and license agreement with Halozyme Therapeutics Inc HALO Per the agreement Bristol Myers will use Halozyme s ENHANZE drug delivery technology This will facilitate subcutaneous administration of Bristol
HALO,HALO:UW,BBG000CZB639,Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%,2017-09-15 14:40:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XqtZLNJiz-o/strength-seen-in-halozyme-therapeutics-halo-stock-soars-212-cm846234,Halozyme Therapeutics Inc HALO was a big mover last session as the company saw its shares rise more than 21 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now
HALO,HALO:UW,BBG000CZB639,Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE,2017-09-15 13:34:01 +0000,https://finance.yahoo.com/news/bristol-myers-bmy-collaborates-halozyme-133401259.html?.tsrc=rss,"Bristol-Myers Squibb Company (BMY) enters into a collaboration and license agreement with Halozyme Therapeutics, Inc. (HALO)."
HALO,HALO:UW,BBG000CZB639,Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%,2017-09-15 12:31:12 +0000,https://finance.yahoo.com/news/strength-seen-halozyme-therapeutics-halo-123112057.html?.tsrc=rss,"Halozyme Therapeutics (HALO) was a big mover last session, as the company saw its shares rise more than 21% on the day amid huge volumes."
HALO,HALO:UW,BBG000CZB639,Today's Research Reports on Stocks to Watch: Halozyme Therapeutics and Array Biopharma,2017-09-15 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000173.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 15, 2017 / Shares of Halozyme hit a new high yesterday and closed the day up over 20% after announcing not one, but three big pieces of news that had traders excited. ..."
HALO,HALO:UW,BBG000CZB639,Stocks To Watch: Halozyme Therapeutics Sees Relative Strength Rating Rise To 90,2017-09-15 07:00:00 +0000,http://finance.yahoo.com/r/df2ae73d-3d90-307b-b2f3-08901a41774e/stocks-to-watch-halozyme-therapeutics-sees-relative-strength-rating-rise-to-90?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Halozyme Therapeutics shows improving technical performance.
HALO,HALO:UW,BBG000CZB639,HALO Just Got Brighter - What Other Pharma Stocks Made News This Week?,2017-09-15 02:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8i9EL_bHw8/halo-just-got-brighter--what-other-pharma-stocks-made-news-this-week-20170915-00044,HALO Just Got Brighter - What Other Pharma Stocks Made News This Week?
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Tenet Healthcare, and AMC Entertainment Holdings Jumped Today",2017-09-14 22:35:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pyT7ntegiLs/why-halozyme-therapeutics-tenet-healthcare-and-amc-entertainment-holdings-jumped-today-cm846004,The stock market was once again mixed on Thursday with the Dow Jones Industrials gaining ground to set a record high for the third session in a row even as other major benchmarks lagged behind Market participants turned their attention to the interest rate arena today weighing
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Tenet Healthcare, and AMC Entertainment Holdings Jumped Today",2017-09-14 20:30:00 +0000,http://finance.yahoo.com/r/cfb6628e-8e93-3cf1-99d9-29bfde2a324e/why-halozyme-therapeutics-tenet-healthcare-and-amc.aspx?yptr=yahoo&.tsrc=rss,"The stock market was mixed, but these stocks climbed. Find out why."
HALO,HALO:UW,BBG000CZB639,"This Small Cap Biotech Soars On Deals With Bristol-Myers, Roche",2017-09-14 20:20:18 +0000,http://finance.yahoo.com/r/34a3e7bb-8bdc-3ad3-8012-586aee24df46/bristol-myers-squibb-teams-with-small-cap-halozyme-in-cancer-immuno-oncology-drugs?src=A00220&yptr=yahoo&.tsrc=rss,Bristol-Myers Squibb is teaming up with Halozyme to test its immuno-oncology drugs as injections using the small cap firm&apos;s technology.
HALO,HALO:UW,BBG000CZB639,Mid-Afternoon Market Update: Dow Gains 50 Points; Glaukos Shares Slide,2017-09-14 19:46:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/unsKU0TwFpI/mid-afternoon-market-update-dow-gains-50-points-glaukos-shares-slide-cm845950,Toward the end of trading Thursday the Dow traded up 0 23 percent to 22 208 83 while the NASDAQ declined 0 36 percent to 6 437 02 The S amp P also fell dropping 0 08 percent to 2 496 33 Leading and Lagging Sectors Thursday afternoon the utilities shares surged 0 47
HALO,HALO:UW,BBG000CZB639,Halozyme to license drug delivery tech to Bristol-Myers a...,2017-09-14 19:43:00 +0000,https://finance.yahoo.com/video/halozyme-license-drug-delivery-tech-194300108.html?.tsrc=rss,Halozyme CEO Dr. Helen Torley speaks with CNBC's Meg Tirrell about the company using technology that makes it easier for patients to take medicine.
HALO,HALO:UW,BBG000CZB639,"Here's Why Halozyme Therapeutics, Inc. Is Soaring Today",2017-09-14 17:38:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l05rMtscnQ4/heres-why-halozyme-therapeutics-inc-is-soaring-today-cm845849,What happened Shares of Halozyme Therapeutics NASDAQ HALO a small cap biotech focused on creating products that help other drugs work more effectively rose by 16 as of 10 45 a m EDT on Thursday Investors can thank a trio of positive news announcements including two
HALO,HALO:UW,BBG000CZB639,Mid-Day Market Update: Crude Oil Up Over 2%; Summit Therapeutics Shares Plunge,2017-09-14 17:16:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lbiGKG0TsEw/mid-day-market-update-crude-oil-up-over-2-summit-therapeutics-shares-plunge-cm845878,Midway through trading Thursday the Dow traded up 0 04 percent to 22 166 06 while the NASDAQ declined 0 21 percent to 6 446 63 The S amp P also fell dropping 0 08 percent to 2 496 40 Leading and Lagging Sectors On Thursday the energy shares surged 0 62 percent Meanwhile
HALO,HALO:UW,BBG000CZB639,Midday Update: Market Averages Mixed After Inflation Data Surprises to the Upside,2017-09-14 17:15:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1NRZVyyRL6s/midday-update-market-averages-mixed-after-inflation-data-surprises-to-the-upside-cm845869,The Dow Jones Industrial Average has erased earlier losses and moved into the plus column on gains in component stocks Boeing BA and United Technologies UTX while the S amp P 500 and Nasdaq continue to languish in negative territory weighed by losses in the technology and
HALO,HALO:UW,BBG000CZB639,"Notable Thursday Option Activity: SN, HALO, TMUS",2017-09-14 16:41:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cyn7TCqhIdg/notable-thursday-option-activity-sn-halo-tmus-cm845790,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Sanchez Energy Corp Symbol SN where a total volume of 28 779 contracts has been traded thus far today a contract volume which is representative of approximately 2 9
HALO,HALO:UW,BBG000CZB639,Mid-Morning Market Update: Markets Mostly Lower; United Natural Foods Profit Beats Expectations,2017-09-14 15:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wg2l5cCyqB4/mid-morning-market-update-markets-mostly-lower-united-natural-foods-profit-beats-expectations-cm845820,Following the market opening Thursday the Dow traded up 0 02 percent to 22 162 84 while the NASDAQ declined 0 35 percent to 6 437 35 The S amp P also fell dropping 0 16 percent to 2 494 45 Leading and Lagging Sectors Thursday morning the energy shares surged 0 55
HALO,HALO:UW,BBG000CZB639,"Here&apos;s Why Halozyme Therapeutics, Inc. Is Soaring Today",2017-09-14 15:45:00 +0000,http://finance.yahoo.com/r/d8b5953b-768c-3033-9317-cac620de7ce6/why-halozyme-therapeutics-inc-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Shareholders can look at a trio of positive updates for today&apos;s big jump.
HALO,HALO:UW,BBG000CZB639,"Futures Pull-Back as Inflation Perks Up, Chinese Economy Slows",2017-09-14 13:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_gJLESCizhU/futures-pull-back-as-inflation-perks-up-chinese-economy-slows-cm845577,U S stock futures added to their earlier losses on the back of inflation data that indicated a measurable improvement in consumer prices The consumer price index increased by a greater than expected 0 4 in August while the core index was up 0 2 both of which could give the Federal
HALO,HALO:UW,BBG000CZB639,Health Care Sector Update for 09/14/2017: HALO,2017-09-14 13:37:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ss0GOav20sU/health-care-sector-update-for-09142017-halo-cm845576,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 8 MRK 0 8 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on ThursdayHealth care shares were mainly unchanged in pre market trade on Thursday
HALO,HALO:UW,BBG000CZB639,"Pre-Market Most Active for Sep 14, 2017 :  FDC, HALO, GM, BTI, SMFG, THC, TVIX, BAC, QQQ, USLV, BLDP, AAPL",2017-09-14 12:55:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-f5Ax2V9LBU/pre-market-most-active-for-sep-14-2017-fdc-halo-gm-bti-smfg-thc-tvix-bac-qqq-uslv-bldp-aapl-cm845543,The NASDAQ 100 Pre Market Indicator is down 10 84 to 5 993 54 The total Pre Market volume is currently 12 738 941 shares traded The following are the most active stocks for the pre market session First Data Corporation FDC is 0 44 at 17 97 with 3 531 522
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Wins Big on Roche License Agreement,2017-09-14 12:45:29 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-wins-big-roche-124529680.html?.tsrc=rss,Halozyme Therapeutics saw its shares make a handy gain early on Thursday after the firm announced that it licensed its Enhanze drug-delivery technology to Roche for exclusive development of an “undisclosed ...
HALO,HALO:UW,BBG000CZB639,Halozyme Pulls Back Off Best Levels But Remains Sharply Higher,2017-09-14 12:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2xharfoTvZU/halozyme-pulls-back-off-best-levels-but-remains-sharply-higher-20170914-00967,Halozyme Pulls Back Off Best Levels But Remains Sharply Higher
HALO,HALO:UW,BBG000CZB639,"Halozyme to license drug delivery tech to Roche, Bristol-Myers",2017-09-14 12:00:58 +0000,https://finance.yahoo.com/news/halozyme-license-drug-delivery-tech-120058631.html?.tsrc=rss,"U.S. drugmaker Halozyme Therapeutics Inc  said on Thursday it would license its drug delivery  technology to Bristol-Myers Squibb Co and Swiss  drugmaker Roche in separate collaborations.  Shares of Halozyme rose 12.7 percent to $14.85 in premarket  trading after the company also raised its 2017 revenue forecast  as a result of the deals.  Halozyme will receive $105 million upfront from  Bristol-Myers, while Roche will pay $30 million upfront for  Halozyme's Enhanze technology that helps quicken the  administration of injectable drugs."
HALO,HALO:UW,BBG000CZB639,Bristol To Pay Halozyme $105 Million To Make New Cancer Drugs Easier To Take,2017-09-14 12:00:00 +0000,http://finance.yahoo.com/r/3121d9c1-42c9-3f66-8da4-8af8c37e4d91/bristol-to-pay-halozyme-105-million-to-make-new-cancer-drugs-easier-to-take?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Bristol-Myers Squibb will pay Halozyme $105 million for the right to use the smaller company's technology to develop easier-to-use versions of its best-selling cancer immunotherapy Opdivo, as well as as many as 11 other drugs in the larger company's research pipeline."
HALO,HALO:UW,BBG000CZB639,Halozyme's stock soars after Bristol-Myers license deal,2017-09-14 11:18:07 +0000,http://finance.yahoo.com/r/3a104c60-47e2-3a34-82b2-f44a0b044c95/Story.aspx?guid=9C294356-1197-4C3D-B292-D1E4AC612FF9&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Halozyme Therapeutics Inc. rocketed 13% in premarket trade Thursday, after the biotechnology company announced a license agreement with Bristol-Myers Squibb Co. , to develop subcutaneously administered ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties",2017-09-14 11:05:00 +0000,https://finance.yahoo.com/news/halozyme-licenses-enhanze-target-30-110500529.html?.tsrc=rss,"SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) announced today it licensed its ENHANZE® drug-delivery technology to Roche for exclusive development of an undisclosed therapeutic target.  Under terms of the agreement, Halozyme will receive an initial $30 million with the potential to earn additional payments of up to $160 million subject to achievement of specified development, regulatory and sales-based milestones.  Halozyme will also receive tiered, mid-single digit royalties on sales of commercialized products."
HALO,HALO:UW,BBG000CZB639,Halozyme Increases 2017 Financial Guidance,2017-09-14 11:05:00 +0000,https://finance.yahoo.com/news/halozyme-increases-2017-financial-guidance-110500474.html?.tsrc=rss,"SAN DIEGO , Sept. 14, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today raised financial guidance for ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers,2017-09-14 11:00:00 +0000,http://finance.yahoo.com/r/ee13ddbd-2f5e-364d-947d-897126906c20/immuno-oncology-deal-with-bristol-myers-could-boost-halozyme.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pharma giant aims to develop cancer drug delivery technology. Halozyme shares are up more than 16% in pre-market trading.
HALO,HALO:UW,BBG000CZB639,Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology,2017-09-14 10:59:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-halozyme-enter-105900615.html?.tsrc=rss,"Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Myers Squibb immuno-oncology medicines using Halozyme’s ENHANZE® drug-delivery technology."
HALO,HALO:UW,BBG000CZB639,Bristol-Myers Partners With Halozyme; Gains Access To ENHANZE Technology,2017-09-14 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3gmVclnHuYY/bristolmyers-partners-with-halozyme-gains-access-to-enhanze-technology-20170914-00336,Bristol-Myers Partners With Halozyme; Gains Access To ENHANZE Technology
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-09-11 12:06:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120628470.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : September 1, 2017",2017-09-01 13:59:57 +0000,http://finance.yahoo.com/r/429e8ade-6474-3201-a23a-bb6c5382a587/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Stocks Generating Improved Relative Strength: Halozyme Therapeutics,2017-08-30 07:00:00 +0000,http://finance.yahoo.com/r/74f3e2e4-c3dd-3e64-8c4f-a1de15a56d76/stocks-generating-improved-relative-strength-halozyme-therapeutics?src=A00220&yptr=yahoo&.tsrc=rss,"Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conferences,2017-08-25 12:00:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-120000212.html?.tsrc=rss,"SAN DIEGO , Aug. 25, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will participate at two upcoming investor ..."
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-08-23 12:05:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120530626.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-08-16 12:06:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120636358.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
HALO,HALO:UW,BBG000CZB639,Analysts Forecast 10% Gains Ahead For VXF,2017-08-14 14:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4aRkhHiYUKg/analysts-forecast-10-gains-ahead-for-vxf-cm831571,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 8-Aug-17 8:30pm GMT,2017-08-13 13:35:49 +0000,https://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-121630473.html?.tsrc=rss,Q2 2017 Halozyme Therapeutics Inc Earnings Call
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-08-12 12:05:20 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120520500.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.,2017-08-11 12:06:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120632909.html?.tsrc=rss,Halozyme Therapeutics Inc NASDAQ/NGS:HALO
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 2Q loss,2017-08-09 03:40:51 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-reports-2q-loss-223535295.html?.tsrc=rss,"On a per-share basis, the San Diego-based company said it had a loss of 23 cents. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Second Quarter 2017 Results,2017-08-08 20:05:00 +0000,https://finance.yahoo.com/news/halozyme-reports-second-quarter-2017-200500321.html?.tsrc=rss,-- Genentech's U.S. RITUXAN HYCELA™ Launch Underway; Lilly Doses First Patient in Clinical Study of New Investigational Therapy Combined with Halozyme ENHANZE® Technology -- -- Total Revenue of $33.8 million ...
HALO,HALO:UW,BBG000CZB639,"Investor Network: Halozyme Therapeutics, Inc. to Host Earnings Call",2017-08-08 14:20:00 +0000,https://finance.yahoo.com/news/investor-network-halozyme-therapeutics-inc-142000410.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 4:30 ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : August 8, 2017",2017-08-08 12:26:10 +0000,http://finance.yahoo.com/r/61067320-c745-3d00-83f2-4f8ccaf63af0/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-august-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conference,2017-08-04 20:15:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-201500248.html?.tsrc=rss,"SAN DIEGO , Aug. 4, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will be presenting at the Canaccord Genuity ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. – Value Analysis (NASDAQ:HALO) : August 4, 2017",2017-08-04 02:37:24 +0000,http://finance.yahoo.com/r/7c6bf5cf-6504-3cc9-87f7-7f24fc3caeda/halozyme-therapeutics-inc-value-analysis-nasdaqhalo-august-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Halozyme Therapeutics, Inc. a score of 25. Our analysis is based on comparing Halozyme Therapeutics, Inc. with the following peers – MannKind Corporation, Baxter International Inc., Eli Lilly and Company, Intrexon Corporation, Peregrine Pharmaceuticals, Inc., Albireo Pharma, Inc., Pfizer Inc., Sanofi Sponsored ADR and Johnson & Johnson ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : July 21, 2017",2017-07-21 12:39:13 +0000,http://finance.yahoo.com/r/d6a7ec6d-69ca-338f-a99c-d2a927f57f91/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-july-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy,2017-07-13 12:30:00 +0000,https://finance.yahoo.com/news/initiation-clinical-trial-collaboration-evaluating-123000811.html?.tsrc=rss,"SAN DIEGO, July 13, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) today announced the initiation of a multi-arm clinical trial evaluating PEGPH20, Halozyme's investigational new drug, in combination with atezolizumab (TECENTRIQ®), an anti-PDL1 cancer immunotherapy from Genentech, a member of the Roche Group.  The combination will be tested in patients with previously treated metastatic pancreatic ductal adenocarcinoma."
HALO,HALO:UW,BBG000CZB639,Investor thought Martin Shkreli was like &apos;Rain Man&apos; character because of his financial focus,2017-07-10 20:39:24 +0000,https://finance.yahoo.com/news/investor-thought-martin-shkreli-apos-203924600.html?.tsrc=rss,But Schuyler Marshall also said it took months of pestering Shkreli to get money back that he had invested in Shkreli&apos;s hedge fund.
HALO,HALO:UW,BBG000CZB639,Investor thought Martin Shkreli was like 'Rain Man' character because of his financial focus,2017-07-10 20:39:24 +0000,http://finance.yahoo.com/r/1a075301-1186-3a54-829f-f38455b2b6c2/104576806?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104576806&yptr=yahoo&.tsrc=rss,But Schuyler Marshall also said it took months of pestering Shkreli to get money back that he had invested in Shkreli's hedge fund.
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Second Quarter 2017 Financial Results Conference Call,2017-07-10 20:15:00 +0000,https://finance.yahoo.com/news/halozyme-host-second-quarter-2017-201500902.html?.tsrc=rss,"SAN DIEGO , July 10, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,Former officer of Martin Shkreli hedge fund filed SEC complaint against Shkreli while at fund,2017-07-07 20:28:58 +0000,https://finance.yahoo.com/news/former-officer-martin-shkreli-hedge-202858782.html?.tsrc=rss,"Jackson Su testified that the &quot;last straw&quot; for him was seeing Shkreli take $10,000 in cash from his drug company&apos;s account, which had just $20,000 in it."
HALO,HALO:UW,BBG000CZB639,Former officer of Martin Shkreli hedge fund filed SEC complaint against Shkreli while at fund,2017-07-07 20:28:58 +0000,http://finance.yahoo.com/r/1d9ac6e6-044e-325a-a40a-6400e23b8295/104573387?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104573387&yptr=yahoo&.tsrc=rss,"Jackson Su testified that the ""last straw"" for him was seeing Shkreli take $10,000 in cash from his drug company's account, which had just $20,000 in it."
HALO,HALO:UW,BBG000CZB639,"Martin Shkreli worker called him &apos;mentally unstable,&apos; threatened to expose lies by &apos;scam artist&apos;",2017-07-07 17:32:09 +0000,https://finance.yahoo.com/news/martin-shkreli-worker-called-him-173209972.html?.tsrc=rss,Stock analyst Caroline Stewart said Shkreli was &quot;very dejected&quot; after losing millions of dollars in a botched short trade.
HALO,HALO:UW,BBG000CZB639,"Martin Shkreli worker called him 'mentally unstable,' threatened to expose lies by 'scam artist'",2017-07-07 17:32:09 +0000,http://finance.yahoo.com/r/b58087b8-1528-39a4-843c-f463c2493edc/104573081?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104573081&yptr=yahoo&.tsrc=rss,"Stock analyst Caroline Stewart said Shkreli was ""very dejected"" after losing millions of dollars in a botched short trade."
HALO,HALO:UW,BBG000CZB639,Former Shkreli employee says 'pharma bro' was deeply depressed after hedge fund 'imploded',2017-07-06 23:02:57 +0000,http://finance.yahoo.com/r/19330c38-23cb-3320-881b-ba9ae836984e/104571627?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104571627&yptr=yahoo&.tsrc=rss,"Stock analyst Caroline Stewart said he first contact with Shkreli featured him mocking her and trying to ""make me feel stupid."""
HALO,HALO:UW,BBG000CZB639,Former Shkreli employee says &apos;pharma bro&apos; was deeply depressed after hedge fund &apos;imploded&apos;,2017-07-06 23:02:57 +0000,https://finance.yahoo.com/news/former-shkreli-employee-says-apos-230257351.html?.tsrc=rss,Stock analyst Caroline Stewart said he first contact with Shkreli featured him mocking her and trying to &quot;make me feel stupid.&quot;
HALO,HALO:UW,BBG000CZB639,"Shkreli kept hedge-fund investor in dark about botched trade, misled him about auditors: testimony",2017-07-06 20:58:03 +0000,http://finance.yahoo.com/r/8a66da12-c6e7-38d4-ab92-af0a77971ea5/104571203?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104571203&yptr=yahoo&.tsrc=rss,"""I was given the option of taking the cash or taking the stock,"" Dr. Lindsay Rosenwald said. ""I wanted the cash ... I didn't get the cash."""
HALO,HALO:UW,BBG000CZB639,"Shkreli kept hedge-fund investor in dark about botched trade, misled him about auditors: testimony",2017-07-06 20:58:03 +0000,https://finance.yahoo.com/news/shkreli-kept-hedge-fund-investor-205803252.html?.tsrc=rss,"&quot;I was given the option of taking the cash or taking the stock,&quot; Dr. Lindsay Rosenwald said. &quot;I wanted the cash ... I didn&apos;t get the cash.&quot;"
HALO,HALO:UW,BBG000CZB639,Martin Shkreli's lawyer and 'cowboy' venture capitalist duel over value of horses and investments,2017-07-06 16:38:28 +0000,http://finance.yahoo.com/r/bb135d54-619b-37e1-8466-442be0485860/104570576?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104570576&yptr=yahoo&.tsrc=rss,"Darren Blanton is one of many investors prosecutors say were defrauded at Shkreli-run hedge funds, and paid off under sham consulting agreements."
HALO,HALO:UW,BBG000CZB639,Martin Shkreli&apos;s lawyer and &apos;cowboy&apos; venture capitalist duel over value of horses and investments,2017-07-06 16:38:28 +0000,https://finance.yahoo.com/news/martin-shkreli-apos-lawyer-apos-163828429.html?.tsrc=rss,"Darren Blanton is one of many investors prosecutors say were defrauded at Shkreli-run hedge funds, and paid off under sham consulting agreements."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : June 30, 2017",2017-06-30 13:27:56 +0000,http://finance.yahoo.com/r/a542e9ce-416c-3402-86d8-bc0d89cc4337/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-june-30-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Halozyme Phase 2 Data In Advanced Pancreas Cancer Presented At European Society For Medical Oncology Symposium,2017-06-28 16:00:00 +0000,https://finance.yahoo.com/news/halozyme-phase-2-data-advanced-160000957.html?.tsrc=rss,"--Findings in Two Oral Presentations and Three Poster Presentations Continue to Support Ongoing HALO-301 Phase 3 Study-- BARCELONA, Spain , June 28, 2017 /PRNewswire/ -- Results from Halozyme Therapeutics ..."
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : June 26, 2017",2017-06-26 20:06:25 +0000,http://finance.yahoo.com/r/681d823a-c9cd-38c6-b312-1c45fc7c371d/etfs-with-exposure-to-halozyme-therapeutics-inc-june-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Halozyme Therapeutics, Inc. Here are 5 ETFs with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Roche's (RHHBY) Combination Cancer Remedy Wins FDA Approval,2017-06-26 15:52:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kf59Vfzgzw0/roches-rhhby-combination-cancer-remedy-wins-fda-approval-cm808067,Roche RHHBY announced that the FDA has granted approval to the subcutaneous injection of its marketed lymphoma drug MabThera Rituxan as Rituxan Hycela for the treatment of adults with different types of blood cancers The injection used Halozyme Therapeutics HALO proprietary
HALO,HALO:UW,BBG000CZB639,"Halozyme FDA Action Date, Q1 Review, Analysts Outlook and Price Targets",2017-06-26 12:00:00 +0000,https://finance.yahoo.com/news/halozyme-fda-action-date-q1-120000252.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ..."
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 9-May-17 8:30pm GMT,2017-06-25 23:36:13 +0000,https://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-124628498.html?.tsrc=rss,Q1 2017 Halozyme Therapeutics Inc Earnings Call
HALO,HALO:UW,BBG000CZB639,InPlay from Briefing.com,2017-06-22 19:55:14 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
HALO,HALO:UW,BBG000CZB639,"FDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE Technology",2017-06-22 19:16:00 +0000,https://finance.yahoo.com/news/fda-approves-genentechs-rituxan-hycela-191600991.html?.tsrc=rss,"SAN DIEGO , June 22, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that the U.S. Food and ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : June 19, 2017",2017-06-19 12:22:54 +0000,http://finance.yahoo.com/r/f0760178-6883-3f5b-8af9-0f1a0bd4fdc8/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"Notable Friday Option Activity: FINL, X, HALO",2017-06-16 21:20:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TPIdtfN2P1Q/notable-friday-option-activity-finl-x-halo-cm804600,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Finish Line Inc Symbol FINL where a total volume of 6 391 contracts has been traded thus far today a contract volume which is representative of approximately 639
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : June 16, 2017",2017-06-16 19:51:15 +0000,http://finance.yahoo.com/r/1b01a4f2-394e-3296-9f09-8cda1fa1e2b7/etfs-with-exposure-to-halozyme-therapeutics-inc-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Halozyme Therapeutics, Inc. Here are 5 ETFs with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Benzinga's Option Alert Recap From June 15,2017-06-15 20:05:46 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-june-200546877.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the options alerts from Thursday, June 15, 2017. All timestamps are in Eastern ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017",2017-06-14 13:15:02 +0000,http://finance.yahoo.com/r/e8a848db-1740-3e08-876b-e171018634bc/halozyme-therapeutics-inc-halo-us-earnings-analysis-q1-2017-by-the-numbers-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Halozyme Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Halozyme Therapeutics, Inc. – MannKind Corporation, Eli Lilly and Company, Baxter International Inc., Intrexon Corporation, Pfizer Inc. and Johnson & Johnson (MNKD-US, LLY-US, BAX-US, XON-US, PFE-US and JNJ-US) ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics Inc. Sank 16.5% in May,2017-06-06 15:03:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/40FDK_f5oD8/why-halozyme-therapeutics-inc-sank-165-in-may-cm799314,What happened Halozyme Therapeutics NASDAQ HALO a biotech focused on creating products that help other drugs work better fell 16 5 in May according to data from S amp P Global Market Intelligence So what Halozyme released its first quarter earnings results
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics Inc. Sank 16.5% in May,2017-06-06 13:14:00 +0000,http://finance.yahoo.com/r/e13fee34-7d50-35d1-b3d1-76f3e7dc76f1/why-halozyme-therapeutics-inc-sank-165-in-may.aspx?yptr=yahoo&.tsrc=rss,News that a secondary stock offering would be taking place at a discounted price caused shares of the developmental stage biotech to swoon.
HALO,HALO:UW,BBG000CZB639,Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO,2017-06-04 15:45:00 +0000,https://finance.yahoo.com/news/halozyme-phase-2-data-advanced-154500296.html?.tsrc=rss,"CHICAGO, June 4, 2017 /PRNewswire/ -- Encouraging results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (HALO) were presented today at the American Society of Clinical Oncology (ASCO) annual conference.  Principal Investigator Sunil R. Hingorani, M.D., Ph.D., a pancreas cancer expert at Fred Hutchinson Cancer Research Center and professor at University of Washington School of Medicine expanded on findings from patient data as of December 2016 in the HALO-202 study of investigational new drug, PEGPH20 (pegvorhyaluronidase alpha) in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine.  PEGPH20 plus standard chemotherapy of ABRAXANE and gemcitabine improved median PFS by 77 percent over chemotherapy alone in HA-High patients."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conferences,2017-05-25 20:05:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-200500501.html?.tsrc=rss,"SAN DIEGO, May 25, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies will be presenting a corporate overview ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares,2017-05-24 20:05:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-announces-completion-public-200500936.html?.tsrc=rss,"SAN DIEGO, May 24, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) announced today the completion of its previously announced underwritten public offering of 11,500,000 shares of its common stock.  The offering included 1,500,000 shares sold pursuant to the full exercise of the underwriters' option to purchase additional shares.  All shares in the offering were sold by Halozyme at a public offering price of $12.50 per share."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : May 22, 2017",2017-05-22 12:38:12 +0000,http://finance.yahoo.com/r/de9eb7f8-e1d8-3594-94b7-df2f1fb61469/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc.'s Necessary Move Sends Shares Down as Much as 10%",2017-05-19 22:12:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ilm29kJ7dg4/halozyme-therapeutics-incs-necessary-move-sends-shares-down-as-much-as-10-cm792170,What happened Shares of Halozyme Therapeutics NASDAQ HALO a drug developer with a keen focus on creating novel therapies to treat cancer dropped as much as 10 during Friday s trading session following the announcement and pricing of a secondary stock offering after
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Seadrill, and Sibanye Gold Slumped Today",2017-05-19 22:12:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hoN6FOQ3Jls/why-halozyme-therapeutics-seadrill-and-sibanye-gold-slumped-today-cm792161,Friday was a good day for the stock market generally as the Dow Jones Industrials finished with triple digit gains and broader benchmarks posted similar gains in percentage terms Fear from earlier in the week about the potential loss of forward momentum for pro investor policies out
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Seadrill, and Sibanye Gold Slumped Today",2017-05-19 20:55:00 +0000,http://finance.yahoo.com/r/c5f97831-8b41-3a19-bf5f-19f1446719f5/why-halozyme-therapeutics-seadrill-and-sibanye-gol.aspx?yptr=yahoo&.tsrc=rss,"Despite big gains for the market, these stocks fell. Find out why."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc.&apos;s Necessary Move Sends Shares Down as Much as 10%",2017-05-19 20:27:00 +0000,http://finance.yahoo.com/r/617d4362-7d72-33bc-a05d-b3bad926b5aa/halozyme-therapeutics-incs-necessary-move-sends-sh.aspx?yptr=yahoo&.tsrc=rss,The need for fresh capital is a plight most drug developers face.
HALO,HALO:UW,BBG000CZB639,Mid-Afternoon Market Update: Dow Climbs 150 Points; Foot Locker Shares Drop On Earnings Miss,2017-05-19 19:41:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HLFZpi54-W0/mid-afternoon-market-update-dow-climbs-150-points-foot-locker-shares-drop-on-earnings-miss-cm792108,Toward the end of trading Friday the Dow traded up 0 75 percent to 20 817 44 while the NASDAQ climbed 0 76 percent to 6 101 02 The S amp P also rose gaining 0 84 percent to 2 385 56 Leading and Lagging Sectors Basic materials sector was the top gainer in the US market on
HALO,HALO:UW,BBG000CZB639,"Friday's ETF Movers: ILF, XBI",2017-05-19 19:12:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zItv7GSAaTU/fridays-etf-movers-ilf-xbi-cm792070,In trading on Friday the iShares Latin America 40 ETF ILF is outperforming other ETFs up about 4 7 on the day Components of that ETF showing particular strength include shares of Gerdau GGB up about 9 8 and shares of Itau Unibanco Banco Multiplo ITUB up about 6 8 on the
HALO,HALO:UW,BBG000CZB639,Mid-Day Market Update: Crude Oil Up 2%; Halozyme Therapeutics Shares Plunge,2017-05-19 17:41:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NkYUpbjqyeY/mid-day-market-update-crude-oil-up-2-halozyme-therapeutics-shares-plunge-cm792057,Midway through trading Friday the Dow traded up 0 47 percent to 20 759 94 while the NASDAQ climbed 0 65 percent to 6 094 68 The S amp P also rose gaining 0 66 percent to 2 381 40 Leading and Lagging Sectors Basic materials sector was the top gainer in the US market on Friday
HALO,HALO:UW,BBG000CZB639,Mid-Morning Market Update: Markets Open Higher; Deere Earnings Beat Views,2017-05-19 15:41:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IxpmfVWV05c/mid-morning-market-update-markets-open-higher-deere-earnings-beat-views-cm791996,Following the market opening Friday the Dow traded up 0 41 percent to 20 747 99 while the NASDAQ climbed 0 59 percent to 6 090 72 The S amp P also rose gaining 0 59 percent to 2 379 58 Leading and Lagging Sectors Basic materials sector was the top gainer in the US market
HALO,HALO:UW,BBG000CZB639,"Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme",2017-05-19 13:16:00 +0000,http://finance.yahoo.com/r/2ff949d0-df36-3b20-99c2-6daa6605f6b6/biotech-movers-lion-biotechnologies-xbiotech-halozyme.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Lion Biotechnologies, XBiotech and Halozyme Therapeutics were among the biotech movers in premarket trading on Friday."
HALO,HALO:UW,BBG000CZB639,"Pre-Market Most Active for May 19, 2017 :  PTXP, DYN, RDS/B, FWONK, QQQ, PBR, SBGL, BAC, XIV, NTEST, HALO, GLYC",2017-05-19 12:51:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5BS4LDZtdmM/pre-market-most-active-for-may-19-2017-ptxp-dyn-rdsb-fwonk-qqq-pbr-sbgl-bac-xiv-ntest-halo-glyc-cm791737,The NASDAQ 100 Pre Market Indicator is up 23 09 to 5 649 4 The total Pre Market volume is currently 6 948 779 shares traded The following are the most active stocks for the pre market session PennTex Midstream Partners LP PTXP is 3 21 at 19 86 with 1 375 947
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Posting Steep Loss After Initial Sell-Off,2017-05-19 12:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TZ6b8AAS1UY/halozyme-therapeutics-posting-steep-loss-after-initial-selloff-20170519-00614,Halozyme Therapeutics Posting Steep Loss After Initial Sell-Off
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Prices Public Offering Of Common Stock,2017-05-19 01:25:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-prices-public-offering-012500300.html?.tsrc=rss,"SAN DIEGO, May 18, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) announced today the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $12.50 per share.  All of the shares in the offering are being sold by Halozyme.  The gross proceeds from this offering are expected to be approximately $125 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Halozyme."
HALO,HALO:UW,BBG000CZB639,Halozyme shares fall after secondary share offering annoucned,2017-05-18 20:49:10 +0000,http://finance.yahoo.com/r/dd023351-e93f-328f-b026-76b72b79ef21/Story.aspx?guid=6EDE8CDA-D3D9-4A05-A76D-C02AC4915519&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Halozyme Therapeutics Inc. shares fell in the extended session Thursday after the cancer-drug biotech company said it was launching a secondary offering of its stock. Halozyme shares fell 8.9% to $12.90 ...
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Announces Public Offering Of Common Stock,2017-05-18 20:05:00 +0000,https://finance.yahoo.com/news/halozyme-therapeutics-announces-public-offering-200500837.html?.tsrc=rss,"SAN DIEGO, May 18, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) announced today that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock.  All of the shares in the offering are to be sold by Halozyme.  Halozyme intends to grant the underwriters a 30-day option to purchase up to $15,000,000 million dollars of additional shares."
HALO,HALO:UW,BBG000CZB639,Blog Coverage: Omeros' Stock Jumped on Completion of IgA nephropathy Cohort and Additional Positive Results,2017-05-18 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-omeros-stock-jumped-121500679.html?.tsrc=rss,"Upcoming AWS Coverage on Halozyme Therapeutics Post-Earnings Results LONDON, UK / ACCESSWIRE / May 18, 2017 / Active Wall St. blog coverage looks at the headline from Omeros Corp. (NASDAQ: OMER ) as the ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Phase 2 Data In Advanced Pancreas Cancer To Be Featured In An Oral Presentation At ASCO,2017-05-17 21:29:00 +0000,https://finance.yahoo.com/news/halozyme-phase-2-data-advanced-212900333.html?.tsrc=rss,"SAN DIEGO, May 17, 2017 /PRNewswire/ -- Results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (HALO) of its targeted investigational therapy, PEGPH20, will be presented in an oral presentation on June 4 at the American Society of Clinical Oncology (ASCO) annual conference.  Principal Investigator Sunil R. Hingorani, M.D., Ph.D., a pancreas cancer expert at Fred Hutchinson Cancer Research Center and professor at University of Washington School of Medicine will present the HALO-202 results, which include the study meeting its primary and key secondary endpoints.  ""The HALO-202 data confirm for the first time in a randomized Phase 2 trial using the current standard of care that a biopsy-based biomarker for hyaluronan content can potentially identify patients who will have a meaningfully greater response when PEGPH20 is added to their treatment,"" said Dr. Hingorani. ""The analysis suggests statistically significant and clinically important progress in this very difficult to treat cancer."
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 9-May-17 8:30pm GMT,2017-05-11 01:31:20 +0000,http://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-124628498.html?.tsrc=rss,Q1 2017 Halozyme Therapeutics Inc Earnings Call
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 1Q loss,2017-05-09 22:10:47 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-reports-1q-loss-221047566.html?.tsrc=rss,The San Diego-based company said it had a loss of 26 cents per share. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was ...
HALO,HALO:UW,BBG000CZB639,Halozyme Reports First Quarter 2017 Financial Results,2017-05-09 20:05:00 +0000,http://finance.yahoo.com/news/halozyme-reports-first-quarter-2017-200500754.html?.tsrc=rss,"SAN DIEGO, May 9, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results and recent ..."
HALO,HALO:UW,BBG000CZB639,"Investor Network: Halozyme Therapeutics, Inc. to Host Earnings Call",2017-05-09 14:15:00 +0000,http://finance.yahoo.com/news/investor-network-halozyme-therapeutics-inc-141500832.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:30 PM Eastern Time. ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. – Value Analysis (NASDAQ:HALO) : April 24, 2017",2017-04-24 19:24:17 +0000,http://finance.yahoo.com/r/97fe5ea8-f940-3528-81e0-7ec293666466/halozyme-therapeutics-inc-value-analysis-nasdaqhalo-april-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Halozyme Therapeutics, Inc. a score of 28. Our analysis is based on comparing Halozyme Therapeutics, Inc. with the following peers – MannKind Corporation, Eli Lilly and Company, Baxter International Inc., Intrexon Corporation, Pfizer Inc., Albireo Pharma, Inc., Peregrine Pharmaceuticals, Inc., Sanofi Sponsored ADR and Johnson & Johnson ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : April 21, 2017",2017-04-21 12:47:31 +0000,http://finance.yahoo.com/r/7f6fbeac-8db7-313e-83f5-54ebd672c1c4/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-april-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss",2017-04-20 22:22:00 +0000,http://finance.yahoo.com/r/244447e3-f947-3080-ad66-4a11cd405378/trading-5-hot-charts-set-to-break-out-soon-for-profit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's how to potentially rake in some fat profits off a number of hot breakout setups.
HALO,HALO:UW,BBG000CZB639,Halozyme To Host First Quarter 2017 Financial Results Conference Call,2017-04-10 20:15:00 +0000,http://finance.yahoo.com/news/halozyme-host-first-quarter-2017-201500803.html?.tsrc=rss,"SAN DIEGO, April 10, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : April 6, 2017",2017-04-06 12:29:07 +0000,http://finance.yahoo.com/r/f0cf5f57-ed33-3bb2-9c90-4db032e895f5/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-april-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Halozyme Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,8:02 am Halozyme Therapeutics' PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models,2017-04-03 12:02:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#halo,8:02 am Halozyme Therapeutics' PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models
HALO,HALO:UW,BBG000CZB639,Halozyme's PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models,2017-04-03 12:00:00 +0000,http://finance.yahoo.com/news/halozymes-pegph20-increases-immune-response-120000151.html?.tsrc=rss,"SAN DIEGO, April 3, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, demonstrated in preclinical models that ..."
HALO,HALO:UW,BBG000CZB639,Halozyme's PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models,2017-04-03 12:00:00 +0000,http://finance.yahoo.com/news/halozymes-pegph20-increases-immune-response-120000151.html,"[PR Newswire] - SAN DIEGO, April 3, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, demonstrated in preclinical models that ..."
HALO,HALO:UW,BBG000CZB639,Rosetta Genomics and Halozyme Therapeutics: Wait for Better News,2017-03-31 13:30:00 +0000,http://finance.yahoo.com/news/rosetta-genomics-halozyme-therapeutics-wait-133000373.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 31, 2017 / Rosetta Genomics and Halozyme Therapeutics both posted losses in Thursday's trading session, on events that were outside of their control. Rosetta saw its earnings ..."
HALO,HALO:UW,BBG000CZB639,Rosetta Genomics and Halozyme Therapeutics: Wait for Better News,2017-03-31 13:30:00 +0000,http://finance.yahoo.com/news/rosetta-genomics-halozyme-therapeutics-wait-133000373.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 31, 2017 / Rosetta Genomics and Halozyme Therapeutics both posted losses in Thursday's trading session, on events that were outside of their control. Rosetta saw its earnings ..."
HALO,HALO:UW,BBG000CZB639,"Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO...",2017-03-30 23:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/087akXeCg3Q/gainers--losers-of-mar30-xbio-pran-aker-tnxp-halo-20170330-01491,"Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO..."
HALO,HALO:UW,BBG000CZB639,"Thursday Sector Laggards: Drugs, Biotechnology Stocks",2017-03-30 17:59:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OmbS318vVGY/thursday-sector-laggards-drugs-biotechnology-stocks-cm767882,In trading on Thursday drugs shares were relative laggards down on the day by about 1 Helping drag down the group were shares of Corbus Pharmaceuticals down about 11 9 and shares of Progenics Pharma off about 9 3 on the day Also lagging the market Thursday are biotechnology
HALO,HALO:UW,BBG000CZB639,"Thursday's ETF Movers: KRE, XBI",2017-03-30 17:59:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cljpiJxtlZ0/thursdays-etf-movers-kre-xbi-cm767880,In trading on Thursday the SPDR S amp P Regional Banking ETF is outperforming other ETFs up about 2 6 on the day Components of that ETF showing particular strength include shares of Private Bancorp up about 5 7 and shares of Ameris Bancorp up about 4 3 on the day And
HALO,HALO:UW,BBG000CZB639,"Here's Why Halozyme Therapeutics, Inc Is Falling",2017-03-30 17:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vd4vvd58B2U/heres-why-halozyme-therapeutics-inc-is-falling-cm767852,What happened After reporting that enrollment in one of its early stage clinical trials has been temporarily suspended shares of Halozyme Therapeutics NASDAQ HALO a small cap biotech focused on creating products that help other drugs work better fell by as much as
HALO,HALO:UW,BBG000CZB639,"Here's Why Halozyme Therapeutics, Inc Is Falling",2017-03-30 15:48:00 +0000,https://www.fool.com/investing/2017/03/30/heres-why-halozyme-therapeutics-inc-is-fallin.aspx,"Here's Why Halozyme Therapeutics, Inc Is Falling"
HALO,HALO:UW,BBG000CZB639,"Here's Why Halozyme Therapeutics, Inc Is Falling",2017-03-30 15:48:00 +0000,http://finance.yahoo.com/r/9bbcbd23-bc90-3460-aeb9-beeb9d1a1b0b/heres-why-halozyme-therapeutics-inc-is-fallin.aspx?yptr=yahoo&.tsrc=rss,Shares drop after the company announced that enrollment in a phase 1b/2 trial pancreatic cancer has been halted.
HALO,HALO:UW,BBG000CZB639,"Biotech Premarket Movers: Halozyme, Omeros, Aralez",2017-03-30 13:54:00 +0000,https://www.thestreet.com/story/14065750/1/biotech-premarket-movers-halozyme-omeros-aralez.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: Halozyme, Omeros, Aralez"
HALO,HALO:UW,BBG000CZB639,"Biotech Premarket Movers: Halozyme, Omeros, Aralez",2017-03-30 13:54:00 +0000,http://finance.yahoo.com/r/10c8cfd6-8a82-34d4-84a6-e1f24dbf006f/biotech-premarket-movers-halozyme-omeros-aralez.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Halozyme Therapeutics, Omeros and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday."
HALO,HALO:UW,BBG000CZB639,Halozyme Provides Update On SWOG Collaborative Group Clinical Study,2017-03-30 12:30:00 +0000,http://finance.yahoo.com/news/halozyme-provides-swog-collaborative-group-123000120.html?.tsrc=rss,"SAN DIEGO, March 30, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced it has been informed by SWOG, an independent network of researchers that design and conduct cancer clinical ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Provides Update On SWOG Collaborative Group Clinical Study,2017-03-30 12:30:00 +0000,http://finance.yahoo.com/news/halozyme-provides-swog-collaborative-group-123000120.html,"[PR Newswire] - SAN DIEGO, March 30, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced it has been informed by SWOG, an independent network of researchers that design and conduct cancer clinical ..."
HALO,HALO:UW,BBG000CZB639,"FDA Snubs MYL, Roche Wins FDA Panel Vote Hands Down, TNXP Falls After-hours",2017-03-30 02:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cJpX67g_YwY/fda-snubs-myl-roche-wins-fda-panel-vote-hands-down-tnxp-falls-afterhours-20170330-00075,"FDA Snubs MYL, Roche Wins FDA Panel Vote Hands Down, TNXP Falls After-hours"
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : March 30, 2017",2017-03-30 00:32:08 +0000,http://finance.yahoo.com/r/0ee097de-6dc0-30c4-ace2-f4f15923fa49/etfs-with-exposure-to-halozyme-therapeutics-inc-march-30-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Halozyme Therapeutics, Inc. Here are 5 ETFs with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : March 30, 2017",2017-03-30 00:32:08 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-march-30-2017/,"ETFs with exposure to Halozyme Therapeutics, Inc. : March 30, 2017"
HALO,HALO:UW,BBG000CZB639,FDA Advisory Committee Provides Unanimous Recommendation For Subcutaneous Rituximab Coformulated With Halozyme Enhanze Technology,2017-03-29 16:44:00 +0000,http://finance.yahoo.com/news/fda-advisory-committee-provides-unanimous-164400432.html,"[PR Newswire] - SAN DIEGO, March 29, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that an Oncologic Drug ..."
HALO,HALO:UW,BBG000CZB639,FDA Advisory Committee Provides Unanimous Recommendation For Subcutaneous Rituximab Coformulated With Halozyme Enhanze Technology,2017-03-29 16:44:00 +0000,http://finance.yahoo.com/news/fda-advisory-committee-provides-unanimous-164400432.html?.tsrc=rss,"SAN DIEGO, March 29, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that an Oncologic Drug ..."
HALO,HALO:UW,BBG000CZB639,10 Small-Cap Stocks That Could Double in the Next 3 Months,2017-03-22 11:45:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GXmyOUmMFgQ/10-small-cap-stocks-that-could-double-in-the-next-3-months-cm763871,InvestorPlace Stock Market News Stock Advice amp Trading Tips Springtime or the second calendar quarter of the year generally isn t a great one for the broad market While the S amp P 500 tends to do well during the first three months of the year it hits a headwind in the
HALO,HALO:UW,BBG000CZB639,"Commit To Purchase Halozyme Therapeutics At $8, Earn 9.4% Using Options",2017-03-21 17:09:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jBliNkpaXeo/commit-to-purchase-halozyme-therapeutics-at-8-earn-94-using-options-cm763610,Investors considering a purchase of Halozyme Therapeutics Inc Symbol HALO stock but tentative about paying the going market price of 13 84 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
HALO,HALO:UW,BBG000CZB639,"Notable Thursday Option Activity: HALO, TIF, WDC",2017-03-16 21:06:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDyHd_ilJWg/notable-thursday-option-activity-halo-tif-wdc-cm761899,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Halozyme Therapeutics Inc Symbol HALO where a total volume of 7 292 contracts has been traded thus far today a contract volume which is representative of
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : March 6, 2017",2017-03-06 18:44:59 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-march-6-2017/,"ETFs with exposure to Halozyme Therapeutics, Inc. : March 6, 2017"
HALO,HALO:UW,BBG000CZB639,HALOZYME THERAPEUTICS INC Financials,2017-03-04 18:04:13 +0000,http://finance.yahoo.com/q/is?s=halo,HALOZYME THERAPEUTICS INC Financials
HALO,HALO:UW,BBG000CZB639,5 Small-Cap Biotech Stocks to Buy in March,2017-03-02 16:15:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3bhidPp-KO0/5-small-cap-biotech-stocks-to-buy-in-march-cm755398,Are you ready for March Madness 160 College basketball playoffs are right around the corner Some might call investing in small cap biotech stocks a different kind of madness While it s true that many of these biotech stocks are very risky some have upcoming catalysts that could
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 15:38:39 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-halo-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017/,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 15:38:39 +0000,http://finance.yahoo.com/r/2d0a2eb3-ceee-39a4-a0a5-41d60631f25f/halozyme-therapeutics-inc-halo-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Halozyme Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Halozyme Therapeutics, Inc. – Eli Lilly and Company, Baxter International Inc., Pfizer Inc., Sanofi Sponsored ADR and Johnson & Johnson (LLY-US, BAX-US, PFE-US, SNY-US and JNJ-US) that have ... Read more    
<b>(Read more...)</b>"
HALO,HALO:UW,BBG000CZB639,5 Small-Cap Biotech Stocks to Buy in March,2017-03-02 14:22:00 +0000,http://finance.yahoo.com/r/9537c74b-0aa6-392c-924d-9c0720f80ed0/5-small-cap-biotech-stocks-to-buy-in-march.aspx?yptr=yahoo&.tsrc=rss,"Why small-cap biotech stocks Coherus BioSciences, Halozyme Therapeutics, PTC Therapeutics, Radius Health, and Spark Therapeutics could soar."
HALO,HALO:UW,BBG000CZB639,5 Small-Cap Biotech Stocks to Buy in March,2017-03-02 14:22:00 +0000,http://www.fool.com/investing/2017/03/02/5-small-cap-biotech-stocks-to-buy-in-march.aspx,5 Small-Cap Biotech Stocks to Buy in March
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 28-Feb-17 9:30pm GMT,2017-03-01 09:03:46 +0000,http://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-090346781.html,Edited Transcript of HALO earnings conference call or presentation 28-Feb-17 9:30pm GMT
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 28-Feb-17 9:30pm GMT,2017-03-01 09:03:46 +0000,http://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-090346781.html?.tsrc=rss,Q4 2016 Halozyme Therapeutics Inc Earnings Call
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition",2017-03-01 00:03:40 +0000,http://biz.yahoo.com/e/170228/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition"
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 10-K, Annual Report",2017-03-01 00:00:39 +0000,http://biz.yahoo.com/e/170228/halo10-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 10-K, Annual Report"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 4Q loss,2017-02-28 21:59:30 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-reports-4q-loss-215930314.html?.tsrc=rss,"On a per-share basis, the San Diego-based company said it had a loss of 21 cents. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 4Q loss,2017-02-28 21:59:30 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-4q-loss-215930578.html,Halozyme Therapeutics reports 4Q loss
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/halozyme-reports-fourth-quarter-full-210500475.html?.tsrc=rss,"SAN DIEGO, Feb. 28, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results and ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/halozyme-reports-fourth-quarter-full-210500475.html,"[PR Newswire] - SAN DIEGO, Feb. 28, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results and ..."
HALO,HALO:UW,BBG000CZB639,Q4 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close,2017-02-28 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=halo,Q4 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season,2017-02-27 15:54:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gUd0U8JUaLQ/why-halozyme-therapeutics-halo-might-surprise-this-earnings-season-cm753504,Investors are always looking for stocks that are poised to beat at earnings season and Halozyme Therapeutics Inc HALO may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Halozyme Therapeutics is
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season,2017-02-27 13:44:01 +0000,http://finance.yahoo.com/news/why-halozyme-therapeutics-halo-might-134401808.html,Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season,2017-02-27 13:44:01 +0000,http://finance.yahoo.com/news/why-halozyme-therapeutics-halo-might-134401808.html?.tsrc=rss,"Halozyme Therapeutics (HALO) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conferences,2017-02-23 21:30:00 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-213000991.html?.tsrc=rss,"SAN DIEGO, Feb. 23, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the Cowen & Company ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conferences,2017-02-23 21:30:00 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-213000991.html,"[PR Newswire] - SAN DIEGO, Feb. 23, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the Cowen & Company ..."
HALO,HALO:UW,BBG000CZB639,"Noteworthy Tuesday Option Activity: PANW, YELP, HALO",2017-02-14 22:18:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FoqaZ2-4n2c/noteworthy-tuesday-option-activity-panw-yelp-halo-cm747932,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Palo Alto Networks Inc Symbol PANW where a total volume of 6 378 contracts has been traded thus far today a contract volume which is representative of approximately 637
HALO,HALO:UW,BBG000CZB639,MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20,2017-02-13 13:30:00 +0000,http://finance.yahoo.com/news/mabvax-therapeutics-studies-lead-investigational-133000830.html?.tsrc=rss,"SAN DIEGO, Feb. 13, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (MBVX), a clinical stage immuno-oncology drug development company, today announced results from a pre-clinical study evaluating the potential benefits of using MabVax's HuMab-5B1antibody, MVT-5873, currently in Phase I clinical trials for the treatment of metastatic pancreatic cancer with Halozyme Therapeutic's (HALO) investigational drug PEGPH20, which targets the tumor microenvironment potentially allowing increased access of co-administered cancer drug therapies to solid tumors.  PEGPH20 is currently in phase III clinical development for metastatic pancreatic cancer and in phase I clinical trials for non-small cell lung cancer, gastric cancer, and metastatic breast cancer.  Results from the preclinical study were positive demonstrating improvement in accumulation of MVT-5873 on tumors in an animal model of pancreatic cancer when administered in sequence with PEGPH20."
HALO,HALO:UW,BBG000CZB639,MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20,2017-02-13 13:30:00 +0000,http://finance.yahoo.com/news/mabvax-therapeutics-studies-lead-investigational-133000830.html,"[PR Newswire] - SAN DIEGO, Feb. 13, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (MBVX), a clinical stage immuno-oncology drug development company, today announced results from a pre-clinical study evaluating the potential benefits of using MabVax's HuMab-5B1antibody, MVT-5873, currently in Phase I clinical trials for the treatment of metastatic pancreatic cancer with Halozyme Therapeutic's (HALO) investigational drug PEGPH20, which targets the tumor microenvironment potentially allowing increased access of co-administered cancer drug therapies to solid tumors. PEGPH20 is currently in phase III clinical development for metastatic pancreatic cancer and in phase I clinical trials for non-small cell lung cancer, gastric cancer, and metastatic breast cancer. Results from the preclinical study were positive demonstrating improvement in accumulation of MVT-5873 on tumors in an animal model of pancreatic cancer when administered in sequence with PEGPH20."
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Jumped 15.6% in January",2017-02-02 15:34:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/orngdU0NJ-M/why-halozyme-therapeutics-inc-jumped-156-in-january-cm742133,Image source Getty Images What happened Shares of Halozyme Therapeutics NASDAQ HALO a commercial stage biopharma rose by more than 15 in January according to data from S amp P Global Market Intelligence HALO data by
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Jumped 15.6% in January",2017-02-02 14:30:07 +0000,http://finance.yahoo.com/r/08eeb087-2ad3-3749-a5a6-e890ce5852d9/why-halozyme-therapeutics-inc-jumped-156-in-januar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,Shares rose in response to the release of upbeat clinical data from an important phase 2 study.
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Jumped 15.6% in January",2017-02-02 14:30:07 +0000,http://www.fool.com/investing/2017/02/02/why-halozyme-therapeutics-inc-jumped-156-in-januar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc. Jumped 15.6% in January"
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Fourth Quarter 2016 Financial Results Conference Call,2017-02-01 21:30:00 +0000,http://finance.yahoo.com/news/halozyme-host-fourth-quarter-2016-213000168.html?.tsrc=rss,"SAN DIEGO, Feb. 1, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Fourth Quarter 2016 Financial Results Conference Call,2017-02-01 21:30:00 +0000,http://finance.yahoo.com/news/halozyme-host-fourth-quarter-2016-213000168.html,"[PR Newswire] - SAN DIEGO, Feb. 1, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : January 27, 2017",2017-01-27 12:56:08 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-january-27-2017/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : January 27, 2017"
HALO,HALO:UW,BBG000CZB639,5 Small-Cap Biotech Stocks to Buy in February,2017-01-26 21:28:51 +0000,http://www.fool.com/investing/2017/01/25/5-small-cap-biotech-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Small-Cap Biotech Stocks to Buy in February
HALO,HALO:UW,BBG000CZB639,5 Small-Cap Biotech Stocks to Buy in February,2017-01-25 22:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fqiiWgVFwR8/5-small-cap-biotech-stocks-to-buy-in-february-cm738331,Looking to add a few thrills to your investing portfolio Small cap biotech stocks should be a good place to start They come with significant risks but the potential rewards are great Here s why Celldex Therapeutics NASDAQ CLDX Geron NASDAQ GERN Halozyme
HALO,HALO:UW,BBG000CZB639,Nektar Therapeutics: An Undervalued Biopharmaceuticals Company With Plenty In The Pipeline,2017-01-20 16:38:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AedYyFhCAB4/nektar-therapeutics-an-undervalued-biopharmaceuticals-company-with-plenty-in-the-pipeline-cm736083,By Robert Lowy ByRobert Lowy Nektar Therapeutics Company Analysis and Recommendation Nektar Therapeutics Company Analysis and RecommendationNektar Therapeutics Company Analysis and Recommendation Date 01 17 2017 Date 01 17 201701 17 2017 Ticker
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : January 17, 2017",2017-01-17 17:02:23 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-january-17-2017/,"ETFs with exposure to Halozyme Therapeutics, Inc. : January 17, 2017"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : January 16, 2017",2017-01-16 13:17:04 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-january-16-2017/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : January 16, 2017"
HALO,HALO:UW,BBG000CZB639,Halozyme Estimates 2017 Revenue of $115M to $130M,2017-01-11 15:10:00 +0000,http://www.investopedia.com/news/halozyme-expects-2017-rev-115m-130m-halo/?partner=YahooSA,Halozyme Estimates 2017 Revenue of $115M to $130M
HALO,HALO:UW,BBG000CZB639,Why trader is selling Halozyme calls,2017-01-11 12:45:06 +0000,http://finance.yahoo.com/news/why-trader-selling-halozyme-calls-124506439.html,Why trader is selling Halozyme calls
HALO,HALO:UW,BBG000CZB639,Here's Why Halozyme Therapeutics Fell as Much as 11.1% Today,2017-01-10 22:52:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nev5oglojgc/heres-why-halozyme-therapeutics-fell-as-much-as-111-today-cm731907,Image source Getty Images What happened Shares of biopharma Halozyme Therapeutics NASDAQ HALO receded over 11 today after the company provided its full year 2017 financial outlook So what The company reported several financial metrics that made investors do a
HALO,HALO:UW,BBG000CZB639,Here's Why Halozyme Therapeutics Fell as Much as 11.1% Today,2017-01-10 20:52:29 +0000,http://www.fool.com/investing/2017/01/10/heres-why-halozyme-therapeutics-fell-as-much-as-11.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Halozyme Therapeutics Fell as Much as 11.1% Today
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4%,2017-01-10 15:55:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/srAx_uSASEU/halozyme-therapeutics-halo-in-focus-stock-up-64-cm731616,Halozyme Therapeutics Inc HALO was a big mover last session as the company saw its shares rise above 6 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics Reaches Analyst Target Price,2017-01-10 15:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ylKyJt0LolE/halozyme-therapeutics-reaches-analyst-target-price-cm731578,In recent trading shares of Halozyme Therapeutics Inc Symbol HALO have crossed above the average analyst 12 month target price of 13 75 changing hands for 14 24 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2017-01-10 14:02:46 +0000,http://biz.yahoo.com/e/170110/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4%,2017-01-10 13:40:01 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-halo-focus-stock-134001867.html,Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4%
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure",2017-01-09 21:14:04 +0000,http://biz.yahoo.com/e/170109/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure"
HALO,HALO:UW,BBG000CZB639,"Halozyme Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare Conference",2017-01-09 21:05:00 +0000,http://finance.yahoo.com/news/halozyme-provides-program-updates-2017-210500791.html,"[PR Newswire] - ""We enter the year with strongly supportive data from our HALO 202 study in metastatic pancreatic cancer patients and momentum in our HALO 301 global registration trial for our investigational new drug PEGPH20 in a similar, targeted HA-High patient population,"" said Dr. Helen Torley, president and chief executive officer. In addition to HALO 301, the company has ongoing studies of PEGPH20 in combination with Merck's KEYTRUDA® (pembrolizumab) in gastric and non-small-cell lung cancer patients and in collaboration with Eisai in combination with HALAVEN® (eribulin) in breast cancer patients. Two new studies exploring four tumor types are planned to start in 2017 as part of a recently announced clinical collaboration with Genentech."
HALO,HALO:UW,BBG000CZB639,Can the Rally in Halozyme (HALO) Shares Continue?,2017-01-09 17:49:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xaD7yg0IMDQ/can-the-rally-in-halozyme-halo-shares-continue-cm731126,Halozyme Therapeutics Inc HALO has been on the move lately as the stock has risen by 15 1 in the past four weeks and it is currently trading well above its 20 Day SMA This is a pretty solid move higher but the question that has to be on investors minds right now is can this
HALO,HALO:UW,BBG000CZB639,Can the Rally in Halozyme (HALO) Shares Continue?,2017-01-09 15:41:03 +0000,http://finance.yahoo.com/news/rally-halozyme-halo-shares-continue-154103909.html,Can the Rally in Halozyme (HALO) Shares Continue?
HALO,HALO:UW,BBG000CZB639,Biotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron,2017-01-09 14:30:00 +0000,http://finance.yahoo.com/news/biotech-industry-off-strong-start-143000493.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 9, 2017 / The Biotech Industry has had a strong start to the year after a rocky 2016. The iShares NASDAQ Biotechnology Index ETF ( IBB ) and the SPDR S&P Biotech ETF ..."
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc Fell 40.6% in 2016",2017-01-06 17:39:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEnQZaSkeUU/why-halozyme-therapeutics-inc-fell-406-in-2016-cm730440,Image source Getty Images What happened Investors in Halozyme Therapeutics NASDAQ HALO 160 a small cap biotech focused on products that enhance drug delivery had a 2016 to forget The company put its shareholders on a gut wrenching roller coaster ride during
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : January 6, 2017",2017-01-06 16:44:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-january-6-2017/,"ETFs with exposure to Halozyme Therapeutics, Inc. : January 6, 2017"
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc Fell 40.6% in 2016",2017-01-06 16:25:56 +0000,http://www.fool.com/investing/2017/01/06/why-halozyme-therapeutics-inc-fell-406-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc Fell 40.6% in 2016"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) Worth a Look: Stock Up 18%,2017-01-06 15:42:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/znI8FQHF-9E/halozyme-therapeutics-halo-worth-a-look-stock-up-18-cm730328,Halozyme Therapeutics Inc HALO was a big mover last session as the company saw its shares rise almost 18 on the day The upside was driven after the company announced robust phase 2 results for its pancreatic cancer drug PEGPH20 The news also led to far more shares changing hands than in
HALO,HALO:UW,BBG000CZB639,"Company News for January 06, 2017",2017-01-06 15:10:03 +0000,http://finance.yahoo.com/news/company-news-january-06-2017-151003108.html,"Company News for January 06, 2017"
HALO,HALO:UW,BBG000CZB639,Halozyme Pancreatic Cancer Drug Succeeds in Trial,2017-01-06 14:45:00 +0000,http://www.investopedia.com/news/halozyme-cancer-drug-does-well-phase-2-halo/?partner=YahooSA,Halozyme Pancreatic Cancer Drug Succeeds in Trial
HALO,HALO:UW,BBG000CZB639,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20,2017-01-06 14:40:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/938soG4ZPVM/halozyme-halo-up-on-positive-phase-ii-data-on-pegph20-cm730339,Shares of Halozyme Therapeutics Inc HALO surged almost 18 after the company announced top line data from the phase II HALO 202 study on PEGPH20 for the treatment of stage IV metastatic pancreatic cancer patients A look at Halozyme s share price movement in 2016 shows that the
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) Worth a Look: Stock Up 18%,2017-01-06 13:30:01 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-halo-worth-look-133001556.html,Halozyme Therapeutics (HALO) Worth a Look: Stock Up 18%
HALO,HALO:UW,BBG000CZB639,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20,2017-01-06 13:19:01 +0000,http://finance.yahoo.com/news/halozyme-halo-positive-phase-ii-131901986.html,Halozyme (HALO) Up on Positive Phase II Data on PEGPH20
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics downgraded by Citigroup,2017-01-06 12:58:02 +0000,http://finance.yahoo.com/q/ud?s=HALO,Halozyme Therapeutics downgraded by Citigroup
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : January 6, 2017",2017-01-06 12:39:21 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-january-6-2017/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : January 6, 2017"
HALO,HALO:UW,BBG000CZB639,"Constellation Brands, Halozyme Therapeutics: Jim Cramer's Top Takeaways",2017-01-06 11:00:00 +0000,https://www.thestreet.com/story/13944609/1/constellation-brands-halozyme-therapeutics-jim-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO,"Constellation Brands, Halozyme Therapeutics: Jim Cramer's Top Takeaways"
HALO,HALO:UW,BBG000CZB639,"OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC",2017-01-06 01:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yOqldRF18G8/otic-hits-right-notes-gemp-to-report-data-this-month-busy-year-ahead-for-rvnc-20170106-00017,"OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC"
HALO,HALO:UW,BBG000CZB639,"Why Barrick Gold, Halozyme Therapeutics, and CEB Jumped Today",2017-01-06 00:37:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KOql_1fMoi4/why-barrick-gold-halozyme-therapeutics-and-ceb-jumped-today-cm730163,Thursday was a mixed day for the stock market as the Nasdaq Composite posted a modest gain even as the Dow and S amp P 500 eased lower For much of the day major market benchmarks were sharply lower in large part because downbeat early readings on the holiday shopping season called
HALO,HALO:UW,BBG000CZB639,Shares of Halozyme spike 17% after positive results for pancreatic cancer drug,2017-01-06 00:09:53 +0000,http://www.cnbc.com/id/104201806?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104201806,Shares of Halozyme spike 17% after positive results for pancreatic cancer drug
HALO,HALO:UW,BBG000CZB639,"Retail, Politics and Bonds Signal Trend Changes: Cramer's 'Mad Money' Recap (Thursday 1/5/17)",2017-01-05 23:59:00 +0000,https://www.thestreet.com/story/13944600/1/retail-politics-and-bonds-signal-trend-changes-cramer-s-mad-money-recap-thursday-1-5-17.html?puc=yahoo&cm_ven=YAHOO,"Retail, Politics and Bonds Signal Trend Changes: Cramer's 'Mad Money' Recap (Thursday 1/5/17)"
HALO,HALO:UW,BBG000CZB639,"Why Barrick Gold, Halozyme Therapeutics, and CEB Jumped Today",2017-01-05 22:33:00 +0000,http://www.fool.com/investing/2017/01/05/why-barrick-gold-halozyme-therapeutics-and-ceb-jum.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Barrick Gold, Halozyme Therapeutics, and CEB Jumped Today"
HALO,HALO:UW,BBG000CZB639,3 ideas to improve waiting for your trades,2017-01-05 21:51:58 +0000,http://finance.yahoo.com/tumblr/blog-3-ideas-to-improve-waiting-for-your-trades-215209047.html,3 ideas to improve waiting for your trades
HALO,HALO:UW,BBG000CZB639,Macy's and Toyota skid; Sears jumps,2017-01-05 21:50:44 +0000,http://sg.finance.yahoo.com/news/macys-toyota-skid-sears-jumps-215044634.html,Macy's and Toyota skid; Sears jumps
HALO,HALO:UW,BBG000CZB639,"Gainers & Losers Of The Day: ETRM, PIRS, GNVC, AEZS, XXII",2017-01-05 21:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b6tapGdr79I/gainers--losers-of-the-day-etrm-pirs-gnvc-aezs-xxii-20170105-01242,"Gainers & Losers Of The Day: ETRM, PIRS, GNVC, AEZS, XXII"
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc Is Rising Today",2017-01-05 17:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v9DnEbi5wsk/why-halozyme-therapeutics-inc-is-rising-today-cm729900,Image source Getty Images What happened Shares of Halozyme Therapeutics NASDAQ HALO a commercial stage 160 biotech focused on creating products that 160 enhance drug delivery rose by as much as 30 in 160 early morning trading on Thursday before settling
HALO,HALO:UW,BBG000CZB639,Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday,2017-01-05 16:40:43 +0000,http://finance.yahoo.com/news/why-5-biopharma-stocks-making-164043079.html,Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc Is Rising Today",2017-01-05 16:25:44 +0000,http://www.fool.com/investing/2017/01/05/why-halozyme-therapeutics-inc-is-rising-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc Is Rising Today"
HALO,HALO:UW,BBG000CZB639,#1 issue top traders want to fix in 2017 on our prop desk,2017-01-05 16:13:40 +0000,http://finance.yahoo.com/tumblr/blog-1-issue-top-traders-want-to-fix-in-2017-on-our-182805496.html,#1 issue top traders want to fix in 2017 on our prop desk
HALO,HALO:UW,BBG000CZB639,Wall Street Tips Lower; Jobless Claims Fall More Than Expected,2017-01-05 14:37:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sv7AjAHaW7k/wall-street-tips-lower-jobless-claims-fall-more-than-expected-cm729710,U S stocks were pointing to a lower open on Thursday as traders evaluated the wider than expected drop in unemployment claims which pointed to a healthy labor market U S stocks were pointing to a lower open on Thursday as traders evaluated the wider than expected drop in unemployment claims
HALO,HALO:UW,BBG000CZB639,"US Futures Nudge Lower Ahead of Jobs, Services Data",2017-01-05 13:56:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hkft_4Cezao/us-futures-nudge-lower-ahead-of-jobs-services-data-cm729659,U S stock futures inched lower on Thursday as traders looked ahead to the release of econonomic data on the labor market and service sector activity U S stock futures inched lower on Thursday as traders looked ahead to the release of econonomic data on the labor market and service
HALO,HALO:UW,BBG000CZB639,"Pre-Market Most Active for Jan 5, 2017 :  HALO, HLX, ICL, JCP, SIRI, M, BAC, KSS, NVDA, MYL, TVIX, GNCA",2017-01-05 13:56:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4to3QhWxghw/pre-market-most-active-for-jan-5-2017-halo-hlx-icl-jcp-siri-m-bac-kss-nvda-myl-tvix-gnca-cm729689,The NASDAQ 100 Pre Market Indicator is up 04 to 4 937 24 The total Pre Market volume is currently 7 360 201 shares traded The following are the most active stocks for the pre market session Halozyme Therapeutics Inc HALO is 1 92 at 12 61 with 2 149 752
HALO,HALO:UW,BBG000CZB639,Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints,2017-01-05 12:34:06 +0000,http://www.publicnow.com/view/D493D5295927C279AC1AB2EE1705B8EB3C082731,[at noodls] - Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints The text version of this document is not available at the moment. The original content was posted at original link . Halozyme ...
HALO,HALO:UW,BBG000CZB639,Halozyme Posting Strong Gain On Positive Clinical Trial Results,2017-01-05 12:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3vwtmaIodjM/halozyme-posting-strong-gain-on-positive-clinical-trial-results-20170105-00885,Halozyme Posting Strong Gain On Positive Clinical Trial Results
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-01-05 12:19:30 +0000,http://biz.yahoo.com/e/170105/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
HALO,HALO:UW,BBG000CZB639,Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints,2017-01-05 12:00:00 +0000,http://finance.yahoo.com/news/halozyme-announces-phase-2-study-120000714.html,"[PR Newswire] - SAN DIEGO, Jan. 5, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO) today reported topline results from the combined analysis of Stages 1 and 2 and Stage 2 alone of its HALO 202 study, a Phase 2 randomized, multi-center clinical trial of lead investigational drug PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine in stage IV pancreas cancer patients. Among the findings, the overall study population showed a statistically significant increase in progression-free survival (PFS) in patients with high levels of hyaluronan (HA-High) treated with PEGPH20 plus ABRAXANE and gemcitabine when compared to HA-High patients receiving ABRAXANE and gemcitabine alone. ""These findings confirm our confidence in the development of PEGPH20 in this difficult to treat cancer,"" said Dr. Helen Torley, president and CEO."
HALO,HALO:UW,BBG000CZB639,HALO Crosses Below Key Moving Average Level,2016-12-22 22:56:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4cCJSHCkry4/halo-crosses-below-key-moving-average-level-cm725398,In trading on Thursday shares of Halozyme Therapeutics Inc Symbol HALO crossed below their 200 day moving average of 10 24 changing hands as low as 10 15 per share Halozyme Therapeutics Inc shares are currently trading down about 5 2 on the day The chart below shows the one
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At The 35th Annual J.P. Morgan Healthcare Conference,2016-12-22 21:30:00 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-present-35th-annual-213000615.html,"[PR Newswire] - SAN DIEGO, Dec. 22, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 35 th Annual ..."
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ",2016-12-19 21:07:33 +0000,http://biz.yahoo.com/e/161219/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ"
HALO,HALO:UW,BBG000CZB639,"Noteworthy Friday Option Activity: JBL, HALO, CALX",2016-12-16 21:57:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjA03UGd3A4/noteworthy-friday-option-activity-jbl-halo-calx-cm722749,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Jabil Circuit Inc Symbol JBL where a total volume of 12 153 contracts has been traded thus far today a contract volume which is representative of approximately 1 2
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. – Value Analysis (NASDAQ:HALO) : December 16, 2016",2016-12-16 15:31:17 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-value-analysis-nasdaqhalo-december-16-2016/,"Halozyme Therapeutics, Inc. – Value Analysis (NASDAQ:HALO) : December 16, 2016"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : December 15, 2016",2016-12-15 12:45:30 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-december-15-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : December 15, 2016"
HALO,HALO:UW,BBG000CZB639,"Is Halozyme Therapeutics, Inc. (HALO) Worthy of Your Portfolio?",2016-12-09 22:03:01 +0000,http://www.insidermonkey.com/blog/is-halozyme-therapeutics-inc-halo-worthy-of-your-portfolio-501915/,"Is Halozyme Therapeutics, Inc. (HALO) Worthy of Your Portfolio?"
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Stock Soared 39.6% in November",2016-12-05 17:33:09 +0000,http://www.fool.com/investing/2016/12/05/why-halozyme-therapeutics-inc-stock-rose-396-in-no.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc. Stock Soared 39.6% in November"
HALO,HALO:UW,BBG000CZB639,"AbbVie Nixes Halozyme Drug Partnership (HALO, ABBV)",2016-11-22 14:55:00 +0000,http://www.investopedia.com/news/abbvie-ends-halozyme-development-deal-halo-abbv/?partner=YahooSA,"AbbVie Nixes Halozyme Drug Partnership (HALO, ABBV)"
HALO,HALO:UW,BBG000CZB639,Abbvie Ends Development Program With Halozyme,2016-11-21 20:25:06 +0000,http://finance.yahoo.com/news/abbvie-ends-development-program-halozyme-202506133.html,Abbvie Ends Development Program With Halozyme
HALO,HALO:UW,BBG000CZB639,Halozyme Provides Update On AbbVie Collaboration,2016-11-21 13:30:00 +0000,http://finance.yahoo.com/news/halozyme-provides-abbvie-collaboration-133000025.html,"[PR Newswire] - SAN DIEGO, Nov. 21, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that AbbVie has discontinued a development program using the Halozyme ENHANZE™ platform technology and ..."
HALO,HALO:UW,BBG000CZB639,"ETFs with exposure to Halozyme Therapeutics, Inc. : November 16, 2016",2016-11-16 18:10:30 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-november-16-2016/,"ETFs with exposure to Halozyme Therapeutics, Inc. : November 16, 2016"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016",2016-11-15 15:43:00 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-halo-us-earnings-analysis-q3-2016-by-the-numbers-november-15-2016/,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : November 11, 2016",2016-11-11 12:09:43 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-november-11-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : November 11, 2016"
HALO,HALO:UW,BBG000CZB639,"ANTH Plunges As Lupus Trial Fails, BMY''s Opdivo Is At It Again, FDA Nod For GILD",2016-11-11 04:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9FyxiTIU2o/anth-plunges-as-lupus-trial-fails-bmys-opdivo-is-at-it-again-fda-nod-for-gild-20161111-00074,"ANTH Plunges As Lupus Trial Fails, BMY''s Opdivo Is At It Again, FDA Nod For GILD"
HALO,HALO:UW,BBG000CZB639,Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types,2016-11-10 13:30:00 +0000,http://finance.yahoo.com/news/halozyme-announces-broad-clinical-collaboration-133000342.html,"[PR Newswire] - SAN DIEGO, Nov. 10, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech developing novel oncology and drug-delivery therapies, and Genentech, a member of the Roche Group, ..."
HALO,HALO:UW,BBG000CZB639,Here's Why These Biopharma Stocks Soared at Least 10% Today,2016-11-10 11:36:59 +0000,http://www.fool.com/investing/2016/11/09/heres-why-biopharma-stocks-soared-at-least-10-toda.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why These Biopharma Stocks Soared at Least 10% Today
HALO,HALO:UW,BBG000CZB639,Here's Why These Biopharma Stocks Soared at Least 10% Today,2016-11-09 23:53:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IvJdPwL40Bg/heres-why-these-biopharma-stocks-soared-at-least-10-today-cm706843,Image source Getty Images What happened Many biopharma stocks are rising at least 10 today as investors are hopeful that the next president and more importantly the balance of power in Congress will not result in stricter regulations on the industry as many had appeared to
HALO,HALO:UW,BBG000CZB639,"Halozyme 3Q Loss $29M, or 23 Cents a Share (HALO)",2016-11-09 17:13:00 +0000,http://www.investopedia.com/news/halozyme-3q-loss-beats-street-estimates-halo/?partner=YahooSA,"Halozyme 3Q Loss $29M, or 23 Cents a Share (HALO)"
HALO,HALO:UW,BBG000CZB639,"Why Did Halozyme Therapeutics, Inc. Plunge 29.5% in October?",2016-11-09 00:55:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sOTOdR5Tato/why-did-halozyme-therapeutics-inc-plunge-295-in-october-cm706028,Image source Getty Images What happened Halozyme Therapeutics Inc NASDAQ HALO a small cap biotech focused on products that enhance drug delivery fell 29 5 in October according to data from S amp P Global Market Intelligence That was much worse that the
HALO,HALO:UW,BBG000CZB639,"Why Did Halozyme Therapeutics, Inc. Plunge 29.5% in October?",2016-11-08 22:49:28 +0000,http://www.fool.com/investing/2016/11/08/why-did-halozyme-therapeutics-inc-plunge-295-in-oc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Did Halozyme Therapeutics, Inc. Plunge 29.5% in October?"
HALO,HALO:UW,BBG000CZB639,Edited Transcript of HALO earnings conference call or presentation 7-Nov-16 9:30pm GMT,2016-11-08 09:14:42 +0000,http://finance.yahoo.com/news/edited-transcript-halo-earnings-conference-091442566.html,Edited Transcript of HALO earnings conference call or presentation 7-Nov-16 9:30pm GMT
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 3Q loss,2016-11-07 22:46:46 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-3q-loss-224646432.html,Halozyme Therapeutics reports 3Q loss
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition",2016-11-07 21:22:14 +0000,http://biz.yahoo.com/e/161107/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition"
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Third Quarter 2016 Financial Results,2016-11-07 21:20:12 +0000,http://www.publicnow.com/view/8977CA5F5D83DF5720CF14F3BA74AEF8AECF15B4,"[at noodls] - SAN DIEGO, Nov. 7, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results and recent highlights for the third quarter ended September 30. ... This is an abstract ..."
HALO,HALO:UW,BBG000CZB639,Q3 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close,2016-11-07 12:07:07 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=halo,Q3 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close
HALO,HALO:UW,BBG000CZB639,FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab,2016-11-03 12:38:12 +0000,http://www.publicnow.com/view/3A74E3AEAA13058FD2ECDE495B1E2B341D481E5B,"[at noodls] - SAN DIEGO, Nov. 3, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has accepted Genentech's Biologics License Application ..."
HALO,HALO:UW,BBG000CZB639,First Eagle Fund of America 3rd Quarter Commentary,2016-10-28 17:17:21 +0000,http://finance.yahoo.com/news/first-eagle-fund-america-3rd-171721390.html,First Eagle Fund of America 3rd Quarter Commentary
HALO,HALO:UW,BBG000CZB639,First Week of June 2017 Options Trading For Halozyme Therapeutics (HALO),2016-10-25 16:26:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5dTj1oPn4MI/first-week-of-june-2017-options-trading-for-halozyme-therapeutics-halo-cm697894,Investors in Halozyme Therapeutics Inc Symbol HALO saw new options begin trading this week for the June 2017 expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 234 days until expiration the newly trading
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : October 18, 2016",2016-10-18 14:28:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-october-18-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : October 18, 2016"
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Third Quarter 2016 Financial Results Conference Call,2016-10-13 20:50:03 +0000,http://www.publicnow.com/view/8DBF7EBBB9E5260347F8C8FE441344F9BD9413F8,"[at noodls] - SAN DIEGO, Oct. 13, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : October 13, 2016",2016-10-13 12:26:30 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-october-13-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : October 13, 2016"
HALO,HALO:UW,BBG000CZB639,Supernus Stock Reverses Downward Despite Good ADHD Drug Trial,2016-10-11 20:31:15 +0000,http://www.investors.com/news/technology/supernus-stock-reverses-near-breakout-despite-adhd-drug-win/,Supernus Stock Reverses Downward Despite Good ADHD Drug Trial
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Stock Jumped 21.2% in September",2016-10-10 15:20:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/asbWcdS9AYU/why-halozyme-therapeutics-inc-stock-jumped-212-in-september-cm691021,Image source Getty Images What happened Shares of Halozyme Therapeutics Inc NASDAQ HALO 160 a biotechnology company focused on enhancing drug delivery rose 21 2 in September according to data from S amp P Global Market Intelligence The stock tanked to
HALO,HALO:UW,BBG000CZB639,"Why Halozyme Therapeutics, Inc. Stock Jumped 21.2% in September",2016-10-10 15:00:07 +0000,http://www.fool.com/investing/2016/10/10/why-halozyme-therapeutics-inc-stock-jumped-212-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Halozyme Therapeutics, Inc. Stock Jumped 21.2% in September"
HALO,HALO:UW,BBG000CZB639,PEGPH20 Selected For Inclusion In Groundbreaking Clinical Trial Initiative Designed To Transform Outcomes For Pancreatic Cancer Patients,2016-10-04 10:28:10 +0000,http://www.publicnow.com/view/1D6C3B5ED6C71CDE177CFEC0E37BC4FEE67308BE,"[at noodls] - SAN DIEGO, Oct. 4, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech developing novel oncology and drug-delivery therapies, today announced that its investigational drug, ..."
HALO,HALO:UW,BBG000CZB639,Stocks Rebound on Deutsche Bank Rumors,2016-10-01 03:21:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B3wJF4RWGTI/stocks-rebound-on-deutsche-bank-rumors-cm687424,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities rebounded on Friday thanks to a relief rally in 160 Deutsche Bank AG USA 160 NYSE DB shares driven by rumors unsubstantiated at this point that
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. (HALO) Keeping Good Company",2016-09-30 22:22:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NGE-efggO9U/halozyme-therapeutics-inc-halo-keeping-good-company-cm687386,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Investing in biotech companies with continued quarterly losses is always a risky endeavor but the technical outlook and partnerships can play an important role in deciding when to get into
HALO,HALO:UW,BBG000CZB639,How Halozyme Uses Enzymes to Deliver Drugs (HALO),2016-09-19 19:56:00 +0000,http://www.investopedia.com/news/how-halozyme-uses-enzymes-deliver-drugs-halo/?partner=YahooSA,How Halozyme Uses Enzymes to Deliver Drugs (HALO)
HALO,HALO:UW,BBG000CZB639,Bullish & Bearish Reversals for the Week,2016-09-19 18:45:00 +0000,http://realmoney.thestreet.com/articles/09/19/2016/bullish-bearish-reversals-week?puc=yahoo&cm_ven=YAHOO,Bullish & Bearish Reversals for the Week
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) Catches Eye: Stock Up 7.9%,2016-09-19 14:23:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kr7k5yptE2Q/halozyme-therapeutics-halo-catches-eye-stock-up-79-cm681171,Halozyme Therapeutics Inc HALO was a big mover last session as the company saw its shares rise almost 8 on the day The stock rallied after Piper Jaffray raised its price target on the stock from 15 to 18 on increased conviction in the long term value of the San Diego based biotech
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) Catches Eye: Stock Up 7.9%,2016-09-19 12:40:12 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-halo-catches-eye-124012415.html,Halozyme Therapeutics (HALO) Catches Eye: Stock Up 7.9%
HALO,HALO:UW,BBG000CZB639,One Reason Why Halozyme Therapeutics (HALO) Stock Is Climbing Today,2016-09-16 19:48:00 +0000,https://www.thestreet.com/story/13743148/1/one-reason-why-halozyme-therapeutics-halo-stock-is-climbing-today.html?puc=yahoo&cm_ven=YAHOO,One Reason Why Halozyme Therapeutics (HALO) Stock Is Climbing Today
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : September 9, 2016",2016-09-09 14:50:56 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-september-9-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : September 9, 2016"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2016 Global Health Care Conference,2016-09-08 20:30:00 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-present-bank-america-203000422.html,"[PR Newswire] - SAN DIEGO, Sept. 8, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the Bank of America ..."
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh",2016-09-01 21:09:32 +0000,http://biz.yahoo.com/e/160901/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh"
HALO,HALO:UW,BBG000CZB639,Halozyme Names Mark J. Gergen As Chief Operating Officer,2016-09-01 13:13:10 +0000,http://www.publicnow.com/view/D88BFA7F830B7DCDFB9416CA483BDCABB7E8E6B0,"[at noodls] - SAN DIEGO, Sept. 1, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech developing novel oncology and drug-delivery therapies, today named biotech veteran Mark J. Gergen ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At Upcoming Healthcare Conferences,2016-08-31 20:15:00 +0000,http://finance.yahoo.com/news/halozyme-therapeutics-present-upcoming-healthcare-201500944.html,"[PR Newswire] - SAN DIEGO, Aug. 31, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the Wells Fargo ..."
HALO,HALO:UW,BBG000CZB639,3 Small-Cap Stocks to Buy in September,2016-08-31 14:59:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wq7e6F4QjLo/3-small-cap-stocks-to-buy-in-september-cm672681,"Image source  Getty Images.  As the old proverb says, ""Good things come in small packages.""  There's little denying that buying and holding tried and true blue chip stocks, as well as large"
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : August 29, 2016",2016-08-29 15:30:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-august-29-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : August 29, 2016"
HALO,HALO:UW,BBG000CZB639,Analysts See 12% Gains Ahead For The Holdings of IYH,2016-08-18 14:46:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IZFD7LpLiCM/analysts-see-12-gains-ahead-for-the-holdings-of-iyh-cm667021,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
HALO,HALO:UW,BBG000CZB639,Biotech Industry on the Upswing after Rocky Start to 2016,2016-08-17 13:29:05 +0000,http://news.investornetwork.com/2016/08/17/biotech-industry-on-the-upswing-after-rocky-start-to-2016/?1=1&1471440545,Biotech Industry on the Upswing after Rocky Start to 2016
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : August 15, 2016",2016-08-15 14:27:12 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-august-15-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : August 15, 2016"
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016",2016-08-12 14:30:46 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-halo-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/,"Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016"
HALO,HALO:UW,BBG000CZB639,Yelp Inc (YELP) Swung To Surprising Profit; A Look at Four Other Earnings Reports,2016-08-10 15:27:23 +0000,http://www.insidermonkey.com/blog/yelp-inc-yelp-swung-to-surprising-profit-a-look-at-four-other-earnings-reports-468416/,Yelp Inc (YELP) Swung To Surprising Profit; A Look at Four Other Earnings Reports
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 2Q loss,2016-08-09 22:02:22 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-2q-loss-220222553.html,Halozyme Therapeutics reports 2Q loss
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Second Quarter 2016 Financial Results,2016-08-09 20:20:10 +0000,http://www.publicnow.com/view/7320842C158D9368FE0286E49B802E9E230B16EB,"[at noodls] - SAN DIEGO, Aug. 9, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results and recent highlights for the second quarter ended June 30. ... This is an abstract of ..."
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition",2016-08-09 20:09:36 +0000,http://biz.yahoo.com/e/160809/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition"
HALO,HALO:UW,BBG000CZB639,"Earnings Reaction History: Halozyme Therapeutics Inc., 37.5% Follow-Through Indicator, 5.4% Sensitive",2016-08-09 19:53:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IqomMK4Njk4/earnings-reaction-history-halozyme-therapeutics-inc-375-follow-through-indicator-54-sensitive-cm662782,"Expected Earnings Release 08 09 2016, After hours Avg. Extended Hours Dollar Volume $951,065 Halozyme Therapeutics Inc. ( HALO ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
HALO,HALO:UW,BBG000CZB639,Q2 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close,2016-08-09 11:07:02 +0000,http://biz.yahoo.com/research/earncal/20160809.html?t=halo,Q2 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close
HALO,HALO:UW,BBG000CZB639,Eisai And Halozyme Initiate Phase 1b/2 Clinical Trial With First Patient Dosing Of Eribulin In Combination With PEGPH20,2016-07-26 13:18:02 +0000,http://www.publicnow.com/view/7889F857FF37FB07C7DBA05F13B133ED6093F33F,"[at noodls] - SAN DIEGO, July 26, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that Eisai Inc. has dosed the first patient in a collaborative phase 1b/2 clinical trial to assess whether ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA,2016-07-25 13:18:05 +0000,http://www.publicnow.com/view/29BE369388DEA65BDFD1469FC202D66879B5AF17,"[at noodls] - SAN DIEGO, July 25, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it has resumed the enrollment and dosing of patients in its ongoing Phase 1b trial evaluating its ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : July 21, 2016",2016-07-21 12:14:15 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-july-21-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : July 21, 2016"
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : July 20, 2016",2016-07-20 16:31:24 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-july-20-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : July 20, 2016"
HALO,HALO:UW,BBG000CZB639,Coverage Initiated on Select Biotech Stocks,2016-07-15 13:14:57 +0000,http://news.investornetwork.com/2016/07/15/coverage-initiated-on-select-biotech-stocks-2/?1=1&1468588497,Coverage Initiated on Select Biotech Stocks
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Second Quarter 2016 Financial Results Conference Call,2016-07-11 20:53:07 +0000,http://www.publicnow.com/view/EE474232BA1B0569DC82EA84965990002FBA312A,"[at noodls] - SAN DIEGO, July 11, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2016 on Tuesday, August 9, 2016 at 4:30 p.m. ..."
HALO,HALO:UW,BBG000CZB639,These 5 Stocks Under $10 Are Set to Soar,2016-07-07 11:27:00 +0000,https://www.thestreet.com/story/13631449/1/these-5-stocks-under-10-are-set-to-soar.html?puc=yahoo&cm_ven=YAHOO,These 5 Stocks Under $10 Are Set to Soar
HALO,HALO:UW,BBG000CZB639,The Quest for an Effective Treatment for Pancreatic Cancer,2016-06-22 12:07:29 +0000,http://news.investornetwork.com/2016/06/22/the-quest-for-an-effective-treatment-for-pancreatic-cancer/?1=1&1466597249,The Quest for an Effective Treatment for Pancreatic Cancer
HALO,HALO:UW,BBG000CZB639,"ETF’s with exposure to Halozyme Therapeutics, Inc. : June 10, 2016",2016-06-10 23:28:00 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-halozyme-therapeutics-inc-june-10-2016/,"ETF’s with exposure to Halozyme Therapeutics, Inc. : June 10, 2016"
HALO,HALO:UW,BBG000CZB639,"Halozyme Announces Agreement To Refinance Debt, Increases 2016 Guidance For Year-End Cash Balance",2016-06-08 13:18:06 +0000,http://www.publicnow.com/view/C8A21B8AC3FF62D27ED6902139C7132E568593F5,"[at noodls] - SAN DIEGO, June 8, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that it has entered into ..."
HALO,HALO:UW,BBG000CZB639,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D",2016-06-08 13:03:42 +0000,http://biz.yahoo.com/e/160608/halo8-k.html,"HALOZYME THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D"
HALO,HALO:UW,BBG000CZB639,Mid-Morning Market Update: Markets Open Higher; Devon Energy To Sell Non-Core Upstream Assets For Around $1 Billion,2016-06-06 15:40:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7RPDDJ3gJYk/mid-morning-market-update-markets-open-higher-devon-energy-to-sell-non-core-upstream-assets-for-around-1-billion-cm630966,"Following the market opening Monday, the Dow traded up 0.54 percent to 17,903.55 while the NASDAQ climbed 0.31 percent to 4,958.00. The S&P also rose, gaining 0.42 percent to 2,107.99.  Leading and Lagging Sectors  Monday"
HALO,HALO:UW,BBG000CZB639,Highlighted Drug Makers From This Year''s Cancer Conference,2016-06-06 12:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-wWQHxfb2iY/highlighted-drug-makers-from-this-years-cancer-conference-20160606-00776,Highlighted Drug Makers From This Year''s Cancer Conference
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : June 6, 2016",2016-06-06 12:26:47 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-halo-us-june-6-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : June 6, 2016"
HALO,HALO:UW,BBG000CZB639,Halozyme Presents Stage One Efficacy And Safety Analysis Of Phase 2 Clinical Study In Metastatic Pancreatic Cancer Patients Treated With PEGPH20,2016-06-04 13:08:06 +0000,http://www.publicnow.com/view/33C9C3846497E19E49E857EDFB54473938AABACA,"[at noodls] - SAN DIEGO, June 4, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced results from a final analysis ..."
HALO,HALO:UW,BBG000CZB639,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : May 26, 2016",2016-05-26 12:16:19 +0000,http://www.capitalcube.com/blog/index.php/halozyme-therapeutics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-halo-us-may-26-2016/,"Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : May 26, 2016"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At The UBS 2016 Global Health Care Conference,2016-05-17 20:42:11 +0000,http://www.publicnow.com/view/2799418B978CA8526EEF1F5100F3C117F4BDE141,"[at noodls] - SAN DIEGO, May 17, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the UBS 2016 Global Health Care Conference in New York, on Tuesday, May 24 at 2:30 p.m. ET/11:30 ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 1Q loss,2016-05-09 20:37:39 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-1q-loss-203739687.html,Halozyme Therapeutics reports 1Q loss
HALO,HALO:UW,BBG000CZB639,Halozyme Reports First Quarter 2016 Financial Results,2016-05-09 20:18:07 +0000,http://www.publicnow.com/view/DFD9DEFBECA2770608A08DC41929601B7005B09A,"[at noodls] - SAN DIEGO, May 9, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, which included an increase in revenue of 128 percent ..."
HALO,HALO:UW,BBG000CZB639,"The Zacks Analyst Blog Highlights: Horizon Pharma, Incyte, Juno Therapeutics, Halozyme Therapeutics and Kite Pharma",2016-05-09 19:20:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zciaROlUbHM/the-zacks-analyst-blog-highlights-horizon-pharma-incyte-juno-therapeutics-halozyme-therapeutics-and-kite-pharma-cm618206,"For Immediate Release Chicago, IL May 09, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"
HALO,HALO:UW,BBG000CZB639,"Earnings Reaction History: Halozyme Therapeutics Inc., 42.9% Follow-Through Indicator, 5.6% Sensitive",2016-05-09 18:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MeqsQjg8DbM/earnings-reaction-history-halozyme-therapeutics-inc-429-follow-through-indicator-56-sensitive-cm618424,"Expected Earnings Release 05 09 2016, After hours Avg. Extended Hours Dollar Volume $883,734 Halozyme Therapeutics Inc. ( HALO ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
HALO,HALO:UW,BBG000CZB639,Halozyme to Host First Quarter 2016 Financial Results Conference Call,2016-04-20 20:50:13 +0000,http://www.publicnow.com/view/807A93C50E411C89FA23DF14897A39674C7E05B2,"[at noodls] - SAN DIEGO, April 20, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter on Monday, May 9 at 4:30 p.m. ET/1:30 p.m. PT. ..."
HALO,HALO:UW,BBG000CZB639,"Noteworthy Tuesday Option Activity: WETF, HALO, PPC",2016-04-19 21:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eegXUJQqL04/noteworthy-tuesday-option-activity-wetf-halo-ppc-cm608583,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in WisdomTree Investments, Inc. (Symbol WETF), where a total volume of 13,504 contracts has been traded thus far today, a contract volume"
HALO,HALO:UW,BBG000CZB639,Halozyme Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment,2016-04-18 20:17:10 +0000,http://www.publicnow.com/view/FC72E00F0C29BC56ADF33516972F9DBEAFE2731B,"[at noodls] - SAN DIEGO, April 18, 2016 /PRNewswire/ -- Halozyme Therapeutics (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced preclinical data for the discovery ..."
HALO,HALO:UW,BBG000CZB639,"Trade of the Day: Halozyme Therapeutics, Inc. (NASDAQ:HALO)",2016-04-18 19:59:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VplYhgpkgiM/trade-of-the-day-halozyme-therapeutics-inc-nasdaqhalo-cm607809,"To receive further updates on this Halozyme Therapeutics, Inc. (NASDAQ  HALO ) trade as well as an alert when it's time to take profits, sign up for"
HALO,HALO:UW,BBG000CZB639,"Health Care Sector Update for 03/01/2016: HALO, NSTG, RMTI",2016-03-01 18:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NUFUe7SPqTc/health-care-sector-update-for-03012016-halo-nstg-rmti-cm586849,"Top Health Care Stocks JNJ +1.49% PZE +0.10% MRK +1.42% ABT +2.49% AMGN +2.72% Health care stocks were mostly higher today, with the NYSE Health Care Index climbing about 0.9% while shares of health care companies in the S&P"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics beats 4Q profit forecasts,2016-02-29 21:35:28 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-beats-4q-profit-213528409.html,Halozyme Therapeutics beats 4Q profit forecasts
HALO,HALO:UW,BBG000CZB639,"Earnings Reaction History: Halozyme Therapeutics Inc., 50.0% Follow-Through Indicator, 11.9% Sensitive",2016-02-29 20:07:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g-kTx12VbKU/earnings-reaction-history-halozyme-therapeutics-inc-500-follow-through-indicator-119-sensitive-cm586307,"Expected Earnings Release 02 29 2016, After hours Avg. Extended Hours Dollar Volume $806,332 Halozyme Therapeutics Inc. ( HALO ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics is Now Oversold,2016-02-18 22:47:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p8UOfFuscO4/halozyme-therapeutics-is-now-oversold-cm581822,"Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis"
HALO,HALO:UW,BBG000CZB639,Why Halozyme Therapeutics Inc Plunged 51% in January,2016-02-06 13:17:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qtU-nw4RQGE/why-halozyme-therapeutics-inc-plunged-51-in-january-cm575871,"What  Investors in human enzyme specialist Halozyme Therapeutics had a month to forget, as its shares lost 51% of their value in January, according to data from S&P Capital IQ.    So what"
HALO,HALO:UW,BBG000CZB639,How The Pieces Add Up: IYH Targets $175,2016-02-04 14:17:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aeobR3NMsto/how-the-pieces-add-up-iyh-targets-175-cm574670,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
HALO,HALO:UW,BBG000CZB639,Halozyme Announces Closing Of $150 Million Royalty-Backed Debt Financing,2016-01-26 21:22:23 +0000,http://www.publicnow.com/view/1E9EEDD1A8EC869D04FB032ACBDF894203EC2EB0,"[at noodls] - , /PRNewswire/ -- (NASDAQ: HALO) today announced that it has closed the previously announced royalty-backed debt transaction with investment funds managed by and . The debt is secured by future royalties ..."
HALO,HALO:UW,BBG000CZB639,The 1 Thing I Wish Someone Had Told Me When I First Started Investing,2016-01-24 16:21:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZRxayYxJfc4/the-1-thing-i-wish-someone-had-told-me-when-i-first-started-investing-cm569532,"Photo by hobvias sudoneighm, Flickr Creative Commons.  No one starts out as a master investor, as many Motley Fool contributors can attest. We were all investing novices at one point, and each"
HALO,HALO:UW,BBG000CZB639,Halozyme Gets $5M as AbbVie Begins Dosing in Humira Trial,2016-01-22 22:24:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cq4BdhUcm5E/halozyme-gets-5m-as-abbvie-begins-dosing-in-humira-trial-cm569314,"Halozyme Therapeutics, Inc . HALO announced that AbbVie, Inc. ABBV has dosed the first patient in a clinical trial, which the latter is conducting to evaluate the safety and pharmacokinetics of Humira using the former's proprietary Enhanze technology. We"
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics (HALO) in Focus: Stock Rises 6.7%,2016-01-21 16:28:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iOT_371ckT0/halozyme-therapeutics-halo-in-focus-stock-rises-67-cm568484,"Halozyme Therapeutics, Inc.HALO was a big mover last session, as the company saw its shares rise roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."
HALO,HALO:UW,BBG000CZB639,Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE™ Technology,2016-01-21 13:56:08 +0000,http://www.noodls.com/view/880C75DAA2D730A8C338987FFAD4C7621C941722,"[at noodls] - , /PRNewswire/ -- (NASDAQ: HALO) today announced that has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE™ technology. ..."
HALO,HALO:UW,BBG000CZB639,Mid-Morning Market Update: Markets Down; JPMorgan Beats Q4 Expectations,2016-01-14 16:24:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gNRqzmIpcU0/mid-morning-market-update-markets-down-jpmorgan-beats-q4-expectations-cm565788,"Following the market opening Thursday, the Dow traded down 0.37 percent to 16,091.80 while the NASDAQ dipped 1.16 percent to 4,473.53. The S&P also fell, dropping 0.53 percent to 1,880.25.  Leading and Lagging Sectors  On"
HALO,HALO:UW,BBG000CZB639,"Halozyme Provides Key Program Updates, 2016 Financial Guidance At 34th Annual JP Morgan Healthcare Conference",2016-01-11 13:58:04 +0000,http://www.noodls.com/view/4085FD0DA7D1771379D09C02A2A6EAD263C02E4F,"[at noodls] - , /PRNewswire/ -- (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today provided key program updates and its Annual financial guidance at the 34 annual . ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics To Present At The 34th Annual J.P. Morgan Healthcare Conference,2016-01-05 21:50:22 +0000,http://www.noodls.com/view/DA792BCD437957BFE2AB43E77F6FFFE5180B4EA4,"[at noodls] - , /PRNewswire/ -- (NASDAQ: HALO) will be presenting at the 34th Annual in on at / . Dr. , president and chief executive officer, will provide a corporate overview. ... This is an abstract of the original ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing,2016-01-04 13:58:03 +0000,http://www.noodls.com/view/BA1E0614D701CF23EFC767FA56EADECAB9A9CA5A,"[at noodls] - , /PRNewswire/ -- (NASDAQ: HALO) today announced that it has entered into a credit agreement, secured by future royalties of ENHANZE™products, received only from Halozyme's collaborations with and . ... ..."
HALO,HALO:UW,BBG000CZB639,Halozyme To Expand With A Satellite Office In San Francisco,2015-11-17 22:31:24 +0000,http://www.noodls.com/view/04F33B93B6BAF6771BBBA120F61276E199B202DA,[at noodls] - Halozyme To Expand With A Satellite Office In San Francisco
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 3Q loss,2015-11-09 23:35:52 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-3q-loss-233552738.html,Halozyme Therapeutics reports 3Q loss
HALO,HALO:UW,BBG000CZB639,Halozyme Reports Third Quarter 2015 Financial Results,2015-11-09 21:16:19 +0000,http://www.noodls.com/view/1D4DAC24EBEE9FF72703572EED2C513D0223AE29,[at noodls] - Halozyme Reports Third Quarter 2015 Financial Results
HALO,HALO:UW,BBG000CZB639,First Patient Dosed in Clinical Trial of Halozyme Investigational Drug PEGPH20 in Combination With Merck Immuno-oncology Drug KEYTRUDA,2015-11-05 13:50:14 +0000,http://www.noodls.com/view/BBD9BCAA3F8592B08F5F49AFF22EEA3655326C6C,"[at noodls] - SAN DIEGO, Nov. 5, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the first patient has received its investigational new drug, PEGPH20 in combination with Merck's KEYTRUDA ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Announces First Clinical Dosing Of Janssen's Daratumumab Using ENHANZE™ Technology,2015-11-04 13:57:08 +0000,http://www.noodls.com/view/61E5E67BF0D0CCC7FCB289BC6EC79F6E0157B668,"[at noodls] - SAN DIEGO, Nov. 4, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Biotech, Inc. has dosed the first patient in a clinical trial evaluating subcutaneous (SC) ..."
HALO,HALO:UW,BBG000CZB639,Halozyme To Host Third Quarter 2015 Financial Results Conference Call,2015-10-19 21:01:02 +0000,http://www.noodls.com/view/5510B699EBDC3B2B9990F9667DB09B91F38AD267,"[at noodls] - SAN DIEGO, Oct. 19, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the third quarter 2015 on Tuesday, November 10 at 4:30 p.m. ET/1:30 ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics beats 2Q profit forecasts,2015-08-10 22:15:47 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-beats-2q-profit-221547641.html,Halozyme Therapeutics beats 2Q profit forecasts
HALO,HALO:UW,BBG000CZB639,Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and Pegph20 in Advanced Breast Cancer,2015-07-31 08:02:00 +0000,http://au.finance.yahoo.com/news/eisai-halozyme-sign-collaboration-agreement-080200558.html,"[ACN Newswire] - TOKYO, July 31, 2015 - (JCN Newswire) - Eisai Co., Ltd. and Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that they have signed a clinical collaboration agreement to evaluate Eisai's anticancer ..."
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics reports 4Q loss,2015-03-02 23:27:40 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-reports-4q-loss-232740719.html,Halozyme Therapeutics reports 4Q loss
HALO,HALO:UW,BBG000CZB639,Halozyme Therapeutics meets 3Q profit forecasts,2014-11-10 23:51:45 +0000,http://sg.finance.yahoo.com/news/halozyme-therapeutics-meets-3q-profit-235145263--finance.html,Halozyme Therapeutics meets 3Q profit forecasts
